id	sid	tid	token	lemma	pos
cord-024076-q9fw7ch1	1	1	key	key	NNP
cord-024076-q9fw7ch1	1	2	:	:	:
cord-024076-q9fw7ch1	1	3	cord-024076-q9fw7ch1	cord-024076-q9fw7ch1	JJ
cord-024076-q9fw7ch1	1	4	authors	author	NNS
cord-024076-q9fw7ch1	1	5	:	:	:
cord-024076-q9fw7ch1	1	6	Manga	Manga	NNP
cord-024076-q9fw7ch1	1	7	,	,	,
cord-024076-q9fw7ch1	1	8	Pravin	Pravin	NNP
cord-024076-q9fw7ch1	1	9	title	title	NN
cord-024076-q9fw7ch1	1	10	:	:	:
cord-024076-q9fw7ch1	1	11	Should	Should	MD
cord-024076-q9fw7ch1	1	12	ACE	ACE	NNP
cord-024076-q9fw7ch1	1	13	Inhibitors	Inhibitors	NNP
cord-024076-q9fw7ch1	1	14	and	and	CC
cord-024076-q9fw7ch1	1	15	Angiotensin	Angiotensin	NNP
cord-024076-q9fw7ch1	1	16	Receptor	Receptor	NNP
cord-024076-q9fw7ch1	1	17	Blockers	Blockers	NNP
cord-024076-q9fw7ch1	2	1	Be	be	VB
cord-024076-q9fw7ch1	2	2	Withdrawn	withdraw	VBN
cord-024076-q9fw7ch1	2	3	in	in	IN
cord-024076-q9fw7ch1	2	4	the	the	DT
cord-024076-q9fw7ch1	2	5	Current	current	JJ
cord-024076-q9fw7ch1	2	6	Setting	setting	NN
cord-024076-q9fw7ch1	2	7	of	of	IN
cord-024076-q9fw7ch1	2	8	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	2	9	Infection	infection	NN
cord-024076-q9fw7ch1	2	10	?	?	.
cord-024076-q9fw7ch1	3	1	date	date	NN
cord-024076-q9fw7ch1	3	2	:	:	:
cord-024076-q9fw7ch1	3	3	2020	2020	CD
cord-024076-q9fw7ch1	3	4	-	-	HYPH
cord-024076-q9fw7ch1	3	5	04	04	CD
cord-024076-q9fw7ch1	3	6	-	-	SYM
cord-024076-q9fw7ch1	3	7	17	17	CD
cord-024076-q9fw7ch1	3	8	journal	journal	NN
cord-024076-q9fw7ch1	3	9	:	:	:
cord-024076-q9fw7ch1	4	1	nan	nan	NNP
cord-024076-q9fw7ch1	4	2	DOI	DOI	NNP
cord-024076-q9fw7ch1	4	3	:	:	:
cord-024076-q9fw7ch1	5	1	10.18772/26180197.2020.v2nsia4	10.18772/26180197.2020.v2nsia4	LS
cord-024076-q9fw7ch1	5	2	sha	sha	NNP
cord-024076-q9fw7ch1	5	3	:	:	:
cord-024076-q9fw7ch1	6	1	2e28fd98d052f849f330655822397d5f178f77e2	2e28fd98d052f849f330655822397d5f178f77e2	CD
cord-024076-q9fw7ch1	6	2	doc_id	doc_id	CD
cord-024076-q9fw7ch1	6	3	:	:	:
cord-024076-q9fw7ch1	6	4	24076	24076	CD
cord-024076-q9fw7ch1	7	1	cord_uid	cord_uid	NN
cord-024076-q9fw7ch1	7	2	:	:	:
cord-024076-q9fw7ch1	8	1	q9fw7ch1	q9fw7ch1	NNP
cord-024076-q9fw7ch1	9	1	nan	nan	NNP
cord-024076-q9fw7ch1	10	1	The	the	DT
cord-024076-q9fw7ch1	10	2	reports	report	NNS
cord-024076-q9fw7ch1	10	3	urging	urge	VBG
cord-024076-q9fw7ch1	10	4	caution	caution	NN
cord-024076-q9fw7ch1	10	5	in	in	IN
cord-024076-q9fw7ch1	10	6	the	the	DT
cord-024076-q9fw7ch1	10	7	use	use	NN
cord-024076-q9fw7ch1	10	8	of	of	IN
cord-024076-q9fw7ch1	10	9	ACE	ace	NN
cord-024076-q9fw7ch1	10	10	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	10	11	and	and	CC
cord-024076-q9fw7ch1	10	12	ARBs	arb	NNS
cord-024076-q9fw7ch1	10	13	for	for	IN
cord-024076-q9fw7ch1	10	14	hypertension	hypertension	NN
cord-024076-q9fw7ch1	10	15	,	,	,
cord-024076-q9fw7ch1	10	16	diabetes	diabetes	NN
cord-024076-q9fw7ch1	10	17	and	and	CC
cord-024076-q9fw7ch1	10	18	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	10	19	disease	disease	NN
cord-024076-q9fw7ch1	10	20	are	be	VBP
cord-024076-q9fw7ch1	10	21	based	base	VBN
cord-024076-q9fw7ch1	10	22	on	on	IN
cord-024076-q9fw7ch1	10	23	laboratory	laboratory	NN
cord-024076-q9fw7ch1	10	24	data	datum	NNS
cord-024076-q9fw7ch1	10	25	which	which	WDT
cord-024076-q9fw7ch1	10	26	found	find	VBD
cord-024076-q9fw7ch1	10	27	that	that	IN
cord-024076-q9fw7ch1	10	28	SARS	SARS	NNP
cord-024076-q9fw7ch1	10	29	-	-	HYPH
cord-024076-q9fw7ch1	10	30	CoV	CoV	NNP
cord-024076-q9fw7ch1	10	31	and	and	CC
cord-024076-q9fw7ch1	10	32	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	10	33	virus	virus	NN
cord-024076-q9fw7ch1	10	34	binds	bind	VBZ
cord-024076-q9fw7ch1	10	35	to	to	IN
cord-024076-q9fw7ch1	10	36	ACE	ace	NN
cord-024076-q9fw7ch1	10	37	2	2	CD
cord-024076-q9fw7ch1	10	38	receptor	receptor	NN
cord-024076-q9fw7ch1	10	39	which	which	WDT
cord-024076-q9fw7ch1	10	40	is	be	VBZ
cord-024076-q9fw7ch1	10	41	found	find	VBN
cord-024076-q9fw7ch1	10	42	in	in	IN
cord-024076-q9fw7ch1	10	43	the	the	DT
cord-024076-q9fw7ch1	10	44	epithelial	epithelial	JJ
cord-024076-q9fw7ch1	10	45	cells	cell	NNS
cord-024076-q9fw7ch1	10	46	of	of	IN
cord-024076-q9fw7ch1	10	47	the	the	DT
cord-024076-q9fw7ch1	10	48	lung	lung	NN
cord-024076-q9fw7ch1	10	49	,	,	,
cord-024076-q9fw7ch1	10	50	kidney	kidney	NN
cord-024076-q9fw7ch1	10	51	,	,	,
cord-024076-q9fw7ch1	10	52	intestine	intestine	NN
cord-024076-q9fw7ch1	10	53	and	and	CC
cord-024076-q9fw7ch1	10	54	blood	blood	NN
cord-024076-q9fw7ch1	10	55	vessels	vessel	NNS
cord-024076-q9fw7ch1	10	56	.	.	.
cord-024076-q9fw7ch1	11	1	(	(	-LRB-
cord-024076-q9fw7ch1	11	2	4	4	CD
cord-024076-q9fw7ch1	11	3	,	,	,
cord-024076-q9fw7ch1	11	4	5	5	CD
cord-024076-q9fw7ch1	11	5	)	)	-RRB-
cord-024076-q9fw7ch1	12	1	The	the	DT
cord-024076-q9fw7ch1	12	2	ACE	ace	NN
cord-024076-q9fw7ch1	12	3	2	2	CD
cord-024076-q9fw7ch1	12	4	is	be	VBZ
cord-024076-q9fw7ch1	12	5	an	an	DT
cord-024076-q9fw7ch1	12	6	integral	integral	JJ
cord-024076-q9fw7ch1	12	7	protein	protein	NN
cord-024076-q9fw7ch1	12	8	and	and	CC
cord-024076-q9fw7ch1	12	9	contributes	contribute	VBZ
cord-024076-q9fw7ch1	12	10	to	to	IN
cord-024076-q9fw7ch1	12	11	a	a	DT
cord-024076-q9fw7ch1	12	12	host	host	NN
cord-024076-q9fw7ch1	12	13	of	of	IN
cord-024076-q9fw7ch1	12	14	physiologic	physiologic	JJ
cord-024076-q9fw7ch1	12	15	functions	function	NNS
cord-024076-q9fw7ch1	12	16	and	and	CC
cord-024076-q9fw7ch1	12	17	is	be	VBZ
cord-024076-q9fw7ch1	12	18	highly	highly	RB
cord-024076-q9fw7ch1	12	19	expressed	express	VBN
cord-024076-q9fw7ch1	12	20	in	in	IN
cord-024076-q9fw7ch1	12	21	alveolar	alveolar	JJ
cord-024076-q9fw7ch1	12	22	cells	cell	NNS
cord-024076-q9fw7ch1	12	23	of	of	IN
cord-024076-q9fw7ch1	12	24	the	the	DT
cord-024076-q9fw7ch1	12	25	lungs	lung	NNS
cord-024076-q9fw7ch1	12	26	,	,	,
cord-024076-q9fw7ch1	12	27	providing	provide	VBG
cord-024076-q9fw7ch1	12	28	the	the	DT
cord-024076-q9fw7ch1	12	29	main	main	JJ
cord-024076-q9fw7ch1	12	30	entry	entry	NN
cord-024076-q9fw7ch1	12	31	site	site	NN
cord-024076-q9fw7ch1	12	32	for	for	IN
cord-024076-q9fw7ch1	12	33	the	the	DT
cord-024076-q9fw7ch1	12	34	virus	virus	NN
cord-024076-q9fw7ch1	12	35	into	into	IN
cord-024076-q9fw7ch1	12	36	human	human	JJ
cord-024076-q9fw7ch1	12	37	hosts	host	NNS
cord-024076-q9fw7ch1	12	38	.	.	.
cord-024076-q9fw7ch1	13	1	(	(	-LRB-
cord-024076-q9fw7ch1	13	2	5	5	LS
cord-024076-q9fw7ch1	13	3	)	)	-RRB-
cord-024076-q9fw7ch1	14	1	Once	once	IN
cord-024076-q9fw7ch1	14	2	the	the	DT
cord-024076-q9fw7ch1	14	3	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	14	4	virus	virus	NN
cord-024076-q9fw7ch1	14	5	binds	bind	VBZ
cord-024076-q9fw7ch1	14	6	to	to	IN
cord-024076-q9fw7ch1	14	7	ACE	ace	NN
cord-024076-q9fw7ch1	14	8	2	2	CD
cord-024076-q9fw7ch1	14	9	and	and	CC
cord-024076-q9fw7ch1	14	10	gains	gain	NNS
cord-024076-q9fw7ch1	14	11	entry	entry	NN
cord-024076-q9fw7ch1	14	12	,	,	,
cord-024076-q9fw7ch1	14	13	it	-PRON-	PRP
cord-024076-q9fw7ch1	14	14	subsequently	subsequently	RB
cord-024076-q9fw7ch1	14	15	downregulates	downregulate	VBZ
cord-024076-q9fw7ch1	14	16	ACE	ace	NN
cord-024076-q9fw7ch1	14	17	2	2	CD
cord-024076-q9fw7ch1	14	18	expression	expression	NN
cord-024076-q9fw7ch1	14	19	.	.	.
cord-024076-q9fw7ch1	15	1	It	-PRON-	PRP
cord-024076-q9fw7ch1	15	2	is	be	VBZ
cord-024076-q9fw7ch1	15	3	postulated	postulate	VBN
cord-024076-q9fw7ch1	15	4	that	that	IN
cord-024076-q9fw7ch1	15	5	this	this	DT
cord-024076-q9fw7ch1	15	6	may	may	MD
cord-024076-q9fw7ch1	15	7	lead	lead	VB
cord-024076-q9fw7ch1	15	8	to	to	IN
cord-024076-q9fw7ch1	15	9	unopposed	unopposed	JJ
cord-024076-q9fw7ch1	15	10	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	15	11	II	II	NNP
cord-024076-q9fw7ch1	15	12	activity	activity	NN
cord-024076-q9fw7ch1	15	13	and	and	CC
cord-024076-q9fw7ch1	15	14	renin	renin	NN
cord-024076-q9fw7ch1	15	15	-	-	HYPH
cord-024076-q9fw7ch1	15	16	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	15	17	-	-	HYPH
cord-024076-q9fw7ch1	15	18	aldosterone	aldosterone	NN
cord-024076-q9fw7ch1	15	19	-	-	HYPH
cord-024076-q9fw7ch1	15	20	system	system	NN
cord-024076-q9fw7ch1	15	21	(	(	-LRB-
cord-024076-q9fw7ch1	15	22	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	15	23	)	)	-RRB-
cord-024076-q9fw7ch1	15	24	activation	activation	NN
cord-024076-q9fw7ch1	15	25	,	,	,
cord-024076-q9fw7ch1	15	26	leading	lead	VBG
cord-024076-q9fw7ch1	15	27	to	to	IN
cord-024076-q9fw7ch1	15	28	neutrophil	neutrophil	NN
cord-024076-q9fw7ch1	15	29	infiltration	infiltration	NN
cord-024076-q9fw7ch1	15	30	into	into	IN
cord-024076-q9fw7ch1	15	31	the	the	DT
cord-024076-q9fw7ch1	15	32	lungs	lung	NNS
cord-024076-q9fw7ch1	15	33	and	and	CC
cord-024076-q9fw7ch1	15	34	lung	lung	NN
cord-024076-q9fw7ch1	15	35	injury	injury	NN
cord-024076-q9fw7ch1	15	36	.	.	.
cord-024076-q9fw7ch1	16	1	(	(	-LRB-
cord-024076-q9fw7ch1	16	2	6	6	CD
cord-024076-q9fw7ch1	16	3	)	)	-RRB-
cord-024076-q9fw7ch1	17	1	However	however	RB
cord-024076-q9fw7ch1	17	2	,	,	,
cord-024076-q9fw7ch1	17	3	ACE	ACE	NNP
cord-024076-q9fw7ch1	17	4	2	2	CD
cord-024076-q9fw7ch1	17	5	also	also	RB
cord-024076-q9fw7ch1	17	6	has	have	VBZ
cord-024076-q9fw7ch1	17	7	potential	potential	JJ
cord-024076-q9fw7ch1	17	8	protective	protective	JJ
cord-024076-q9fw7ch1	17	9	effects	effect	NNS
cord-024076-q9fw7ch1	17	10	in	in	IN
cord-024076-q9fw7ch1	17	11	that	that	IN
cord-024076-q9fw7ch1	17	12	it	-PRON-	PRP
cord-024076-q9fw7ch1	17	13	counters	counter	VBZ
cord-024076-q9fw7ch1	17	14	the	the	DT
cord-024076-q9fw7ch1	17	15	effects	effect	NNS
cord-024076-q9fw7ch1	17	16	of	of	IN
cord-024076-q9fw7ch1	17	17	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	17	18	II	II	NNP
cord-024076-q9fw7ch1	17	19	via	via	IN
cord-024076-q9fw7ch1	17	20	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	17	21	1	1	CD
cord-024076-q9fw7ch1	17	22	receptor	receptor	NN
cord-024076-q9fw7ch1	17	23	activation	activation	NN
cord-024076-q9fw7ch1	17	24	,	,	,
cord-024076-q9fw7ch1	17	25	by	by	IN
cord-024076-q9fw7ch1	17	26	promoting	promote	VBG
cord-024076-q9fw7ch1	17	27	the	the	DT
cord-024076-q9fw7ch1	17	28	conversion	conversion	NN
cord-024076-q9fw7ch1	17	29	of	of	IN
cord-024076-q9fw7ch1	17	30	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	17	31	II	II	NNP
cord-024076-q9fw7ch1	17	32	to	to	IN
cord-024076-q9fw7ch1	17	33	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	17	34	1	1	CD
cord-024076-q9fw7ch1	17	35	-	-	SYM
cord-024076-q9fw7ch1	17	36	7	7	CD
cord-024076-q9fw7ch1	17	37	,	,	,
cord-024076-q9fw7ch1	17	38	which	which	WDT
cord-024076-q9fw7ch1	17	39	in	in	IN
cord-024076-q9fw7ch1	17	40	turn	turn	NN
cord-024076-q9fw7ch1	17	41	modestly	modestly	RB
cord-024076-q9fw7ch1	17	42	lowers	lower	VBZ
cord-024076-q9fw7ch1	17	43	blood	blood	NN
cord-024076-q9fw7ch1	17	44	pressure	pressure	NN
cord-024076-q9fw7ch1	17	45	through	through	IN
cord-024076-q9fw7ch1	17	46	vasodilatation	vasodilatation	NN
cord-024076-q9fw7ch1	17	47	and	and	CC
cord-024076-q9fw7ch1	17	48	increases	increase	VBZ
cord-024076-q9fw7ch1	17	49	renal	renal	JJ
cord-024076-q9fw7ch1	17	50	excretion	excretion	NN
cord-024076-q9fw7ch1	17	51	of	of	IN
cord-024076-q9fw7ch1	17	52	sodium	sodium	NN
cord-024076-q9fw7ch1	17	53	and	and	CC
cord-024076-q9fw7ch1	17	54	water	water	NN
cord-024076-q9fw7ch1	17	55	.	.	.
cord-024076-q9fw7ch1	18	1	ACE	ace	NN
cord-024076-q9fw7ch1	18	2	2	2	CD
cord-024076-q9fw7ch1	18	3	may	may	MD
cord-024076-q9fw7ch1	18	4	also	also	RB
cord-024076-q9fw7ch1	18	5	attenuate	attenuate	VB
cord-024076-q9fw7ch1	18	6	inflammation	inflammation	NN
cord-024076-q9fw7ch1	18	7	through	through	IN
cord-024076-q9fw7ch1	18	8	the	the	DT
cord-024076-q9fw7ch1	18	9	activation	activation	NN
cord-024076-q9fw7ch1	18	10	of	of	IN
cord-024076-q9fw7ch1	18	11	nitric	nitric	JJ
cord-024076-q9fw7ch1	18	12	oxide	oxide	NN
cord-024076-q9fw7ch1	18	13	pathways	pathway	NNS
cord-024076-q9fw7ch1	18	14	.	.	.
cord-024076-q9fw7ch1	19	1	In	in	IN
cord-024076-q9fw7ch1	19	2	some	some	DT
cord-024076-q9fw7ch1	19	3	experimental	experimental	JJ
cord-024076-q9fw7ch1	19	4	studies	study	NNS
cord-024076-q9fw7ch1	19	5	with	with	IN
cord-024076-q9fw7ch1	19	6	animal	animal	NN
cord-024076-q9fw7ch1	19	7	models	model	NNS
cord-024076-q9fw7ch1	19	8	,	,	,
cord-024076-q9fw7ch1	19	9	it	-PRON-	PRP
cord-024076-q9fw7ch1	19	10	has	have	VBZ
cord-024076-q9fw7ch1	19	11	been	be	VBN
cord-024076-q9fw7ch1	19	12	shown	show	VBN
cord-024076-q9fw7ch1	19	13	that	that	IN
cord-024076-q9fw7ch1	19	14	there	there	EX
cord-024076-q9fw7ch1	19	15	is	be	VBZ
cord-024076-q9fw7ch1	19	16	increased	increase	VBN
cord-024076-q9fw7ch1	19	17	expression	expression	NN
cord-024076-q9fw7ch1	19	18	and	and	CC
cord-024076-q9fw7ch1	19	19	activity	activity	NN
cord-024076-q9fw7ch1	19	20	of	of	IN
cord-024076-q9fw7ch1	19	21	ACE	ace	NN
cord-024076-q9fw7ch1	19	22	2	2	CD
cord-024076-q9fw7ch1	19	23	in	in	IN
cord-024076-q9fw7ch1	19	24	the	the	DT
cord-024076-q9fw7ch1	19	25	heart	heart	NN
cord-024076-q9fw7ch1	19	26	and	and	CC
cord-024076-q9fw7ch1	19	27	brain	brain	NN
cord-024076-q9fw7ch1	19	28	after	after	IN
cord-024076-q9fw7ch1	19	29	treatment	treatment	NN
cord-024076-q9fw7ch1	19	30	with	with	IN
cord-024076-q9fw7ch1	19	31	ACE	ACE	NNP
cord-024076-q9fw7ch1	19	32	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	19	33	and	and	CC
cord-024076-q9fw7ch1	19	34	ARBs.(7	arbs.(7	NN
cord-024076-q9fw7ch1	19	35	)	)	-RRB-
cord-024076-q9fw7ch1	20	1	Furthermore	furthermore	RB
cord-024076-q9fw7ch1	20	2	,	,	,
cord-024076-q9fw7ch1	20	3	the	the	DT
cord-024076-q9fw7ch1	20	4	upregulation	upregulation	NN
cord-024076-q9fw7ch1	20	5	of	of	IN
cord-024076-q9fw7ch1	20	6	ACE	ace	NN
cord-024076-q9fw7ch1	20	7	2	2	CD
cord-024076-q9fw7ch1	20	8	in	in	IN
cord-024076-q9fw7ch1	20	9	humans	human	NNS
cord-024076-q9fw7ch1	20	10	is	be	VBZ
cord-024076-q9fw7ch1	20	11	supported	support	VBN
cord-024076-q9fw7ch1	20	12	by	by	IN
cord-024076-q9fw7ch1	20	13	recent	recent	JJ
cord-024076-q9fw7ch1	20	14	evidence	evidence	NN
cord-024076-q9fw7ch1	20	15	showing	show	VBG
cord-024076-q9fw7ch1	20	16	an	an	DT
cord-024076-q9fw7ch1	20	17	increased	increase	VBN
cord-024076-q9fw7ch1	20	18	secretion	secretion	NN
cord-024076-q9fw7ch1	20	19	of	of	IN
cord-024076-q9fw7ch1	20	20	ACE	ace	NN
cord-024076-q9fw7ch1	20	21	2	2	CD
cord-024076-q9fw7ch1	20	22	in	in	IN
cord-024076-q9fw7ch1	20	23	the	the	DT
cord-024076-q9fw7ch1	20	24	urine	urine	NN
cord-024076-q9fw7ch1	20	25	of	of	IN
cord-024076-q9fw7ch1	20	26	hypertensive	hypertensive	JJ
cord-024076-q9fw7ch1	20	27	patients	patient	NNS
cord-024076-q9fw7ch1	20	28	treated	treat	VBN
cord-024076-q9fw7ch1	20	29	with	with	IN
cord-024076-q9fw7ch1	20	30	olmesartan	olmesartan	NNP
cord-024076-q9fw7ch1	20	31	,	,	,
cord-024076-q9fw7ch1	20	32	an	an	DT
cord-024076-q9fw7ch1	20	33	ARB	arb	NN
cord-024076-q9fw7ch1	20	34	.	.	.
cord-024076-q9fw7ch1	21	1	(	(	-LRB-
cord-024076-q9fw7ch1	21	2	8)	8)	NNP
cord-024076-q9fw7ch1	22	1	Although	although	IN
cord-024076-q9fw7ch1	22	2	ACE	ace	NN
cord-024076-q9fw7ch1	22	3	2	2	CD
cord-024076-q9fw7ch1	22	4	receptor	receptor	NN
cord-024076-q9fw7ch1	22	5	upregulation	upregulation	NN
cord-024076-q9fw7ch1	22	6	may	may	MD
cord-024076-q9fw7ch1	22	7	be	be	VB
cord-024076-q9fw7ch1	22	8	induced	induce	VBN
cord-024076-q9fw7ch1	22	9	by	by	IN
cord-024076-q9fw7ch1	22	10	ACE	ACE	NNP
cord-024076-q9fw7ch1	22	11	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	22	12	and	and	CC
cord-024076-q9fw7ch1	22	13	ARB	arb	NN
cord-024076-q9fw7ch1	22	14	treatment	treatment	NN
cord-024076-q9fw7ch1	22	15	and	and	CC
cord-024076-q9fw7ch1	22	16	hence	hence	RB
cord-024076-q9fw7ch1	22	17	a	a	DT
cord-024076-q9fw7ch1	22	18	theoretical	theoretical	JJ
cord-024076-q9fw7ch1	22	19	risk	risk	NN
cord-024076-q9fw7ch1	22	20	of	of	IN
cord-024076-q9fw7ch1	22	21	increased	increase	VBN
cord-024076-q9fw7ch1	22	22	susceptibility	susceptibility	NN
cord-024076-q9fw7ch1	22	23	to	to	IN
cord-024076-q9fw7ch1	22	24	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	22	25	infection	infection	NN
cord-024076-q9fw7ch1	22	26	,	,	,
cord-024076-q9fw7ch1	22	27	currently	currently	RB
cord-024076-q9fw7ch1	22	28	there	there	EX
cord-024076-q9fw7ch1	22	29	is	be	VBZ
cord-024076-q9fw7ch1	22	30	no	no	DT
cord-024076-q9fw7ch1	22	31	data	data	NN
cord-024076-q9fw7ch1	22	32	that	that	WDT
cord-024076-q9fw7ch1	22	33	has	have	VBZ
cord-024076-q9fw7ch1	22	34	demonstrated	demonstrate	VBN
cord-024076-q9fw7ch1	22	35	a	a	DT
cord-024076-q9fw7ch1	22	36	definitive	definitive	JJ
cord-024076-q9fw7ch1	22	37	causal	causal	JJ
cord-024076-q9fw7ch1	22	38	relationship	relationship	NN
cord-024076-q9fw7ch1	22	39	between	between	IN
cord-024076-q9fw7ch1	22	40	ACE	ace	NN
cord-024076-q9fw7ch1	22	41	2	2	CD
cord-024076-q9fw7ch1	22	42	activity	activity	NN
cord-024076-q9fw7ch1	22	43	and	and	CC
cord-024076-q9fw7ch1	22	44	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	22	45	mortality	mortality	NN
cord-024076-q9fw7ch1	22	46	.	.	.
cord-024076-q9fw7ch1	23	1	Interestingly	interestingly	RB
cord-024076-q9fw7ch1	23	2	,	,	,
cord-024076-q9fw7ch1	23	3	ACE	ACE	NNP
cord-024076-q9fw7ch1	23	4	2	2	CD
cord-024076-q9fw7ch1	23	5	and	and	CC
cord-024076-q9fw7ch1	23	6	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	23	7	1	1	CD
cord-024076-q9fw7ch1	23	8	-	-	SYM
cord-024076-q9fw7ch1	23	9	7	7	CD
cord-024076-q9fw7ch1	23	10	may	may	MD
cord-024076-q9fw7ch1	23	11	in	in	IN
cord-024076-q9fw7ch1	23	12	fact	fact	NN
cord-024076-q9fw7ch1	23	13	have	have	VB
cord-024076-q9fw7ch1	23	14	a	a	DT
cord-024076-q9fw7ch1	23	15	salutatory	salutatory	JJ
cord-024076-q9fw7ch1	23	16	role	role	NN
cord-024076-q9fw7ch1	23	17	in	in	IN
cord-024076-q9fw7ch1	23	18	the	the	DT
cord-024076-q9fw7ch1	23	19	lungs	lung	NNS
cord-024076-q9fw7ch1	23	20	since	since	IN
cord-024076-q9fw7ch1	23	21	it	-PRON-	PRP
cord-024076-q9fw7ch1	23	22	has	have	VBZ
cord-024076-q9fw7ch1	23	23	been	be	VBN
cord-024076-q9fw7ch1	23	24	found	find	VBN
cord-024076-q9fw7ch1	23	25	to	to	TO
cord-024076-q9fw7ch1	23	26	be	be	VB
cord-024076-q9fw7ch1	23	27	protective	protective	JJ
cord-024076-q9fw7ch1	23	28	in	in	IN
cord-024076-q9fw7ch1	23	29	a	a	DT
cord-024076-q9fw7ch1	23	30	number	number	NN
cord-024076-q9fw7ch1	23	31	of	of	IN
cord-024076-q9fw7ch1	23	32	lung	lung	NN
cord-024076-q9fw7ch1	23	33	injury	injury	NN
cord-024076-q9fw7ch1	23	34	models	model	NNS
cord-024076-q9fw7ch1	23	35	.	.	.
cord-024076-q9fw7ch1	24	1	In	in	IN
cord-024076-q9fw7ch1	24	2	a	a	DT
cord-024076-q9fw7ch1	24	3	mouse	mouse	NN
cord-024076-q9fw7ch1	24	4	model	model	NN
cord-024076-q9fw7ch1	24	5	with	with	IN
cord-024076-q9fw7ch1	24	6	acid	acid	NN
cord-024076-q9fw7ch1	24	7	lung	lung	NN
cord-024076-q9fw7ch1	24	8	injury	injury	NN
cord-024076-q9fw7ch1	24	9	,	,	,
cord-024076-q9fw7ch1	24	10	ACE	ace	NN
cord-024076-q9fw7ch1	24	11	2	2	CD
cord-024076-q9fw7ch1	24	12	downregulation	downregulation	NN
cord-024076-q9fw7ch1	24	13	induced	induce	VBN
cord-024076-q9fw7ch1	24	14	by	by	IN
cord-024076-q9fw7ch1	24	15	SARS	SARS	NNP
cord-024076-q9fw7ch1	24	16	-	-	HYPH
cord-024076-q9fw7ch1	24	17	CoV	CoV	NNP
cord-024076-q9fw7ch1	24	18	,	,	,
cord-024076-q9fw7ch1	24	19	the	the	DT
cord-024076-q9fw7ch1	24	20	virus	virus	NN
cord-024076-q9fw7ch1	24	21	responsible	responsible	JJ
cord-024076-q9fw7ch1	24	22	for	for	IN
cord-024076-q9fw7ch1	24	23	the	the	DT
cord-024076-q9fw7ch1	24	24	SARS	SARS	NNP
cord-024076-q9fw7ch1	24	25	virus	virus	NN
cord-024076-q9fw7ch1	24	26	outbreak	outbreak	NN
cord-024076-q9fw7ch1	24	27	in	in	IN
cord-024076-q9fw7ch1	24	28	2003	2003	CD
cord-024076-q9fw7ch1	24	29	,	,	,
cord-024076-q9fw7ch1	24	30	worsened	worsen	VBD
cord-024076-q9fw7ch1	24	31	lung	lung	NN
cord-024076-q9fw7ch1	24	32	injury	injury	NN
cord-024076-q9fw7ch1	24	33	,	,	,
cord-024076-q9fw7ch1	24	34	but	but	CC
cord-024076-q9fw7ch1	24	35	this	this	DT
cord-024076-q9fw7ch1	24	36	lung	lung	NN
cord-024076-q9fw7ch1	24	37	injury	injury	NN
cord-024076-q9fw7ch1	24	38	was	be	VBD
cord-024076-q9fw7ch1	24	39	improved	improve	VBN
cord-024076-q9fw7ch1	24	40	by	by	IN
cord-024076-q9fw7ch1	24	41	therapy	therapy	NN
cord-024076-q9fw7ch1	24	42	with	with	IN
cord-024076-q9fw7ch1	24	43	an	an	DT
cord-024076-q9fw7ch1	24	44	ARB.(9	arb.(9	NN
cord-024076-q9fw7ch1	24	45	)	)	-RRB-
cord-024076-q9fw7ch1	25	1	These	these	DT
cord-024076-q9fw7ch1	25	2	findings	finding	NNS
cord-024076-q9fw7ch1	25	3	suggest	suggest	VBP
cord-024076-q9fw7ch1	25	4	that	that	IN
cord-024076-q9fw7ch1	25	5	SARS	SARS	NNP
cord-024076-q9fw7ch1	25	6	-	-	HYPH
cord-024076-q9fw7ch1	25	7	CoV	CoV	NNP
cord-024076-q9fw7ch1	25	8	may	may	MD
cord-024076-q9fw7ch1	25	9	induce	induce	VB
cord-024076-q9fw7ch1	25	10	lung	lung	NN
cord-024076-q9fw7ch1	25	11	injury	injury	NN
cord-024076-q9fw7ch1	25	12	,	,	,
cord-024076-q9fw7ch1	25	13	but	but	CC
cord-024076-q9fw7ch1	25	14	the	the	DT
cord-024076-q9fw7ch1	25	15	injury	injury	NN
cord-024076-q9fw7ch1	25	16	can	can	MD
cord-024076-q9fw7ch1	25	17	be	be	VB
cord-024076-q9fw7ch1	25	18	ameliorated	ameliorate	VBN
cord-024076-q9fw7ch1	25	19	by	by	IN
cord-024076-q9fw7ch1	25	20	ARB	ARB	NNP
cord-024076-q9fw7ch1	25	21	administration.(9	administration.(9	NNP
cord-024076-q9fw7ch1	25	22	)	)	-RRB-
cord-024076-q9fw7ch1	26	1	These	these	DT
cord-024076-q9fw7ch1	26	2	preclinical	preclinical	JJ
cord-024076-q9fw7ch1	26	3	findings	finding	NNS
cord-024076-q9fw7ch1	26	4	suggest	suggest	VBP
cord-024076-q9fw7ch1	26	5	a	a	DT
cord-024076-q9fw7ch1	26	6	possible	possible	JJ
cord-024076-q9fw7ch1	26	7	protective	protective	JJ
cord-024076-q9fw7ch1	26	8	role	role	NN
cord-024076-q9fw7ch1	26	9	of	of	IN
cord-024076-q9fw7ch1	26	10	ARB	ARB	NNP
cord-024076-q9fw7ch1	26	11	in	in	IN
cord-024076-q9fw7ch1	26	12	SARS	SARS	NNP
cord-024076-q9fw7ch1	26	13	-	-	HYPH
cord-024076-q9fw7ch1	26	14	CoVassociated	CoVassociated	NNP
cord-024076-q9fw7ch1	26	15	lung	lung	NN
cord-024076-q9fw7ch1	26	16	injury	injury	NN
cord-024076-q9fw7ch1	26	17	and	and	CC
cord-024076-q9fw7ch1	26	18	lend	lend	VB
cord-024076-q9fw7ch1	26	19	credence	credence	NN
cord-024076-q9fw7ch1	26	20	to	to	IN
cord-024076-q9fw7ch1	26	21	the	the	DT
cord-024076-q9fw7ch1	26	22	hypothesis	hypothesis	NN
cord-024076-q9fw7ch1	26	23	that	that	IN
cord-024076-q9fw7ch1	26	24	primary	primary	JJ
cord-024076-q9fw7ch1	26	25	activation	activation	NN
cord-024076-q9fw7ch1	26	26	of	of	IN
cord-024076-q9fw7ch1	26	27	the	the	DT
cord-024076-q9fw7ch1	26	28	RAAS	raa	NNS
cord-024076-q9fw7ch1	26	29	in	in	IN
cord-024076-q9fw7ch1	26	30	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	26	31	patients	patient	NNS
cord-024076-q9fw7ch1	26	32	,	,	,
cord-024076-q9fw7ch1	26	33	rather	rather	RB
cord-024076-q9fw7ch1	26	34	than	than	IN
cord-024076-q9fw7ch1	26	35	its	-PRON-	PRP$
cord-024076-q9fw7ch1	26	36	inhibition	inhibition	NN
cord-024076-q9fw7ch1	26	37	,	,	,
cord-024076-q9fw7ch1	26	38	renders	render	VBZ
cord-024076-q9fw7ch1	26	39	them	-PRON-	PRP
cord-024076-q9fw7ch1	26	40	more	more	RBR
cord-024076-q9fw7ch1	26	41	prone	prone	JJ
cord-024076-q9fw7ch1	26	42	to	to	IN
cord-024076-q9fw7ch1	26	43	a	a	DT
cord-024076-q9fw7ch1	26	44	deleterious	deleterious	JJ
cord-024076-q9fw7ch1	26	45	outcome	outcome	NN
cord-024076-q9fw7ch1	26	46	.	.	.
cord-024076-q9fw7ch1	27	1	However	however	RB
cord-024076-q9fw7ch1	27	2	,	,	,
cord-024076-q9fw7ch1	27	3	currently	currently	RB
cord-024076-q9fw7ch1	27	4	there	there	EX
cord-024076-q9fw7ch1	27	5	is	be	VBZ
cord-024076-q9fw7ch1	27	6	no	no	DT
cord-024076-q9fw7ch1	27	7	clinical	clinical	JJ
cord-024076-q9fw7ch1	27	8	evidence	evidence	NN
cord-024076-q9fw7ch1	27	9	that	that	WDT
cord-024076-q9fw7ch1	27	10	has	have	VBZ
cord-024076-q9fw7ch1	27	11	proven	prove	VBN
cord-024076-q9fw7ch1	27	12	that	that	IN
cord-024076-q9fw7ch1	27	13	ACE	ACE	NNP
cord-024076-q9fw7ch1	27	14	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	27	15	or	or	CC
cord-024076-q9fw7ch1	27	16	ARB	arb	NN
cord-024076-q9fw7ch1	27	17	-	-	HYPH
cord-024076-q9fw7ch1	27	18	induced	induce	VBN
cord-024076-q9fw7ch1	27	19	ACE	ace	NN
cord-024076-q9fw7ch1	27	20	2	2	CD
cord-024076-q9fw7ch1	27	21	activity	activity	NN
cord-024076-q9fw7ch1	27	22	is	be	VBZ
cord-024076-q9fw7ch1	27	23	an	an	DT
cord-024076-q9fw7ch1	27	24	effective	effective	JJ
cord-024076-q9fw7ch1	27	25	therapy	therapy	NN
cord-024076-q9fw7ch1	27	26	for	for	IN
cord-024076-q9fw7ch1	27	27	COVID-19-induced	COVID-19-induced	NNP
cord-024076-q9fw7ch1	27	28	lung	lung	NN
cord-024076-q9fw7ch1	27	29	injury	injury	NN
cord-024076-q9fw7ch1	27	30	.	.	.
cord-024076-q9fw7ch1	28	1	In	in	IN
cord-024076-q9fw7ch1	28	2	addition	addition	NN
cord-024076-q9fw7ch1	28	3	,	,	,
cord-024076-q9fw7ch1	28	4	ACE	ace	NN
cord-024076-q9fw7ch1	28	5	2	2	CD
cord-024076-q9fw7ch1	28	6	activity	activity	NN
cord-024076-q9fw7ch1	28	7	may	may	MD
cord-024076-q9fw7ch1	28	8	not	not	RB
cord-024076-q9fw7ch1	28	9	correlate	correlate	VB
cord-024076-q9fw7ch1	28	10	with	with	IN
cord-024076-q9fw7ch1	28	11	the	the	DT
cord-024076-q9fw7ch1	28	12	degree	degree	NN
cord-024076-q9fw7ch1	28	13	of	of	IN
cord-024076-q9fw7ch1	28	14	severity	severity	NN
cord-024076-q9fw7ch1	28	15	of	of	IN
cord-024076-q9fw7ch1	28	16	infection	infection	NN
cord-024076-q9fw7ch1	28	17	with	with	IN
cord-024076-q9fw7ch1	28	18	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	28	19	infection	infection	NN
cord-024076-q9fw7ch1	28	20	.	.	.
cord-024076-q9fw7ch1	29	1	Although	although	IN
cord-024076-q9fw7ch1	29	2	ACE	ace	NN
cord-024076-q9fw7ch1	29	3	2	2	CD
cord-024076-q9fw7ch1	29	4	is	be	VBZ
cord-024076-q9fw7ch1	29	5	presumed	presume	VBN
cord-024076-q9fw7ch1	29	6	to	to	TO
cord-024076-q9fw7ch1	29	7	be	be	VB
cord-024076-q9fw7ch1	29	8	an	an	DT
cord-024076-q9fw7ch1	29	9	important	important	JJ
cord-024076-q9fw7ch1	29	10	mediator	mediator	NN
cord-024076-q9fw7ch1	29	11	for	for	IN
cord-024076-q9fw7ch1	29	12	SARS	SARS	NNP
cord-024076-q9fw7ch1	29	13	-	-	HYPH
cord-024076-q9fw7ch1	29	14	CoV	CoV	NNP
cord-024076-q9fw7ch1	29	15	infection	infection	NN
cord-024076-q9fw7ch1	29	16	,	,	,
cord-024076-q9fw7ch1	29	17	the	the	DT
cord-024076-q9fw7ch1	29	18	absence	absence	NN
cord-024076-q9fw7ch1	29	19	of	of	IN
cord-024076-q9fw7ch1	29	20	SARS	SARS	NNP
cord-024076-q9fw7ch1	29	21	-	-	HYPH
cord-024076-q9fw7ch1	29	22	CoV	CoV	NNP
cord-024076-q9fw7ch1	29	23	has	have	VBZ
cord-024076-q9fw7ch1	29	24	been	be	VBN
cord-024076-q9fw7ch1	29	25	found	find	VBN
cord-024076-q9fw7ch1	29	26	in	in	IN
cord-024076-q9fw7ch1	29	27	some	some	DT
cord-024076-q9fw7ch1	29	28	cell	cell	NN
cord-024076-q9fw7ch1	29	29	types	type	NNS
cord-024076-q9fw7ch1	29	30	expressing	express	VBG
cord-024076-q9fw7ch1	29	31	ACE	ace	NN
cord-024076-q9fw7ch1	29	32	2.(10	2.(10	CD
cord-024076-q9fw7ch1	29	33	)	)	-RRB-
cord-024076-q9fw7ch1	30	1	On	on	IN
cord-024076-q9fw7ch1	30	2	the	the	DT
cord-024076-q9fw7ch1	30	3	other	other	JJ
cord-024076-q9fw7ch1	30	4	hand	hand	NN
cord-024076-q9fw7ch1	30	5	,	,	,
cord-024076-q9fw7ch1	30	6	infection	infection	NN
cord-024076-q9fw7ch1	30	7	was	be	VBD
cord-024076-q9fw7ch1	30	8	present	present	JJ
cord-024076-q9fw7ch1	30	9	in	in	IN
cord-024076-q9fw7ch1	30	10	cells	cell	NNS
cord-024076-q9fw7ch1	30	11	apparently	apparently	RB
cord-024076-q9fw7ch1	30	12	lacking	lack	VBG
cord-024076-q9fw7ch1	30	13	ACE	ace	NN
cord-024076-q9fw7ch1	30	14	2	2	CD
cord-024076-q9fw7ch1	30	15	,	,	,
cord-024076-q9fw7ch1	30	16	suggesting	suggest	VBG
cord-024076-q9fw7ch1	30	17	that	that	IN
cord-024076-q9fw7ch1	30	18	additional	additional	JJ
cord-024076-q9fw7ch1	30	19	co	co	NNS
cord-024076-q9fw7ch1	30	20	-	-	NNS
cord-024076-q9fw7ch1	30	21	factors	factor	NNS
cord-024076-q9fw7ch1	30	22	may	may	MD
cord-024076-q9fw7ch1	30	23	be	be	VB
cord-024076-q9fw7ch1	30	24	needed	need	VBN
cord-024076-q9fw7ch1	30	25	for	for	IN
cord-024076-q9fw7ch1	30	26	adequate	adequate	JJ
cord-024076-q9fw7ch1	30	27	cellular	cellular	JJ
cord-024076-q9fw7ch1	30	28	infection	infection	NN
cord-024076-q9fw7ch1	30	29	.	.	.
cord-024076-q9fw7ch1	31	1	(	(	-LRB-
cord-024076-q9fw7ch1	31	2	10	10	CD
cord-024076-q9fw7ch1	31	3	)	)	-RRB-
cord-024076-q9fw7ch1	32	1	Because	because	IN
cord-024076-q9fw7ch1	32	2	of	of	IN
cord-024076-q9fw7ch1	32	3	the	the	DT
cord-024076-q9fw7ch1	32	4	connection	connection	NN
cord-024076-q9fw7ch1	32	5	of	of	IN
cord-024076-q9fw7ch1	32	6	the	the	DT
cord-024076-q9fw7ch1	32	7	ACE	ace	NN
cord-024076-q9fw7ch1	32	8	2	2	CD
cord-024076-q9fw7ch1	32	9	pathway	pathway	NN
cord-024076-q9fw7ch1	32	10	with	with	IN
cord-024076-q9fw7ch1	32	11	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	32	12	infection	infection	NN
cord-024076-q9fw7ch1	32	13	,	,	,
cord-024076-q9fw7ch1	32	14	there	there	EX
cord-024076-q9fw7ch1	32	15	has	have	VBZ
cord-024076-q9fw7ch1	32	16	been	be	VBN
cord-024076-q9fw7ch1	32	17	widespread	widespread	JJ
cord-024076-q9fw7ch1	32	18	concern	concern	NN
cord-024076-q9fw7ch1	32	19	amongst	amongst	IN
cord-024076-q9fw7ch1	32	20	physicians	physician	NNS
cord-024076-q9fw7ch1	32	21	and	and	CC
cord-024076-q9fw7ch1	32	22	patients	patient	NNS
cord-024076-q9fw7ch1	32	23	,	,	,
cord-024076-q9fw7ch1	32	24	whether	whether	IN
cord-024076-q9fw7ch1	32	25	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	32	26	antagonists	antagonist	NNS
cord-024076-q9fw7ch1	32	27	such	such	JJ
cord-024076-q9fw7ch1	32	28	as	as	IN
cord-024076-q9fw7ch1	32	29	ACE	ace	NN
cord-024076-q9fw7ch1	32	30	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	32	31	and	and	CC
cord-024076-q9fw7ch1	32	32	ARBs	arb	NNS
cord-024076-q9fw7ch1	32	33	confer	confer	VBP
cord-024076-q9fw7ch1	32	34	an	an	DT
cord-024076-q9fw7ch1	32	35	increased	increase	VBN
cord-024076-q9fw7ch1	32	36	risk	risk	NN
cord-024076-q9fw7ch1	32	37	of	of	IN
cord-024076-q9fw7ch1	32	38	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	32	39	infection	infection	NN
cord-024076-q9fw7ch1	32	40	.	.	.
cord-024076-q9fw7ch1	33	1	Many	many	JJ
cord-024076-q9fw7ch1	33	2	patients	patient	NNS
cord-024076-q9fw7ch1	33	3	and	and	CC
cord-024076-q9fw7ch1	33	4	their	-PRON-	PRP$
cord-024076-q9fw7ch1	33	5	physicians	physician	NNS
cord-024076-q9fw7ch1	33	6	,	,	,
cord-024076-q9fw7ch1	33	7	including	include	VBG
cord-024076-q9fw7ch1	33	8	those	those	DT
cord-024076-q9fw7ch1	33	9	in	in	IN
cord-024076-q9fw7ch1	33	10	South	South	NNP
cord-024076-q9fw7ch1	33	11	Africa	Africa	NNP
cord-024076-q9fw7ch1	33	12	,	,	,
cord-024076-q9fw7ch1	33	13	have	have	VBP
cord-024076-q9fw7ch1	33	14	contemplated	contemplate	VBN
cord-024076-q9fw7ch1	33	15	a	a	DT
cord-024076-q9fw7ch1	33	16	cessation	cessation	NN
cord-024076-q9fw7ch1	33	17	of	of	IN
cord-024076-q9fw7ch1	33	18	ACE	ACE	NNP
cord-024076-q9fw7ch1	33	19	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	33	20	or	or	CC
cord-024076-q9fw7ch1	33	21	ARB	ARB	NNP
cord-024076-q9fw7ch1	33	22	medications	medication	NNS
cord-024076-q9fw7ch1	33	23	.	.	.
cord-024076-q9fw7ch1	34	1	In	in	IN
cord-024076-q9fw7ch1	34	2	the	the	DT
cord-024076-q9fw7ch1	34	3	Wuhan	Wuhan	NNP
cord-024076-q9fw7ch1	34	4	study	study	NN
cord-024076-q9fw7ch1	34	5	,	,	,
cord-024076-q9fw7ch1	34	6	(	(	-LRB-
cord-024076-q9fw7ch1	34	7	2	2	LS
cord-024076-q9fw7ch1	34	8	)	)	-RRB-
cord-024076-q9fw7ch1	34	9	there	there	EX
cord-024076-q9fw7ch1	34	10	was	be	VBD
cord-024076-q9fw7ch1	34	11	no	no	DT
cord-024076-q9fw7ch1	34	12	information	information	NN
cord-024076-q9fw7ch1	34	13	of	of	IN
cord-024076-q9fw7ch1	34	14	how	how	WRB
cord-024076-q9fw7ch1	34	15	many	many	JJ
cord-024076-q9fw7ch1	34	16	of	of	IN
cord-024076-q9fw7ch1	34	17	the	the	DT
cord-024076-q9fw7ch1	34	18	patients	patient	NNS
cord-024076-q9fw7ch1	34	19	with	with	IN
cord-024076-q9fw7ch1	34	20	severe	severe	JJ
cord-024076-q9fw7ch1	34	21	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	34	22	infection	infection	NN
cord-024076-q9fw7ch1	34	23	were	be	VBD
cord-024076-q9fw7ch1	34	24	on	on	IN
cord-024076-q9fw7ch1	34	25	ACE	ACE	NNP
cord-024076-q9fw7ch1	34	26	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	34	27	or	or	CC
cord-024076-q9fw7ch1	34	28	ARBs	arb	NNS
cord-024076-q9fw7ch1	34	29	.	.	.
cord-024076-q9fw7ch1	35	1	Furthermore	furthermore	RB
cord-024076-q9fw7ch1	35	2	,	,	,
cord-024076-q9fw7ch1	35	3	there	there	EX
cord-024076-q9fw7ch1	35	4	are	be	VBP
cord-024076-q9fw7ch1	35	5	no	no	DT
cord-024076-q9fw7ch1	35	6	published	publish	VBN
cord-024076-q9fw7ch1	35	7	studies	study	NNS
cord-024076-q9fw7ch1	35	8	to	to	IN
cord-024076-q9fw7ch1	35	9	date	date	NN
cord-024076-q9fw7ch1	35	10	showing	show	VBG
cord-024076-q9fw7ch1	35	11	that	that	IN
cord-024076-q9fw7ch1	35	12	diabetes	diabetes	NN
cord-024076-q9fw7ch1	35	13	and	and	CC
cord-024076-q9fw7ch1	35	14	hypertension	hypertension	NN
cord-024076-q9fw7ch1	35	15	are	be	VBP
cord-024076-q9fw7ch1	35	16	independent	independent	JJ
cord-024076-q9fw7ch1	35	17	predictors	predictor	NNS
cord-024076-q9fw7ch1	35	18	of	of	IN
cord-024076-q9fw7ch1	35	19	mortality	mortality	NN
cord-024076-q9fw7ch1	35	20	with	with	IN
cord-024076-q9fw7ch1	35	21	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	35	22	infection	infection	NN
cord-024076-q9fw7ch1	35	23	.	.	.
cord-024076-q9fw7ch1	36	1	Thus	thus	RB
cord-024076-q9fw7ch1	36	2	,	,	,
cord-024076-q9fw7ch1	36	3	a	a	DT
cord-024076-q9fw7ch1	36	4	clear	clear	JJ
cord-024076-q9fw7ch1	36	5	causal	causal	JJ
cord-024076-q9fw7ch1	36	6	relationship	relationship	NN
cord-024076-q9fw7ch1	36	7	between	between	IN
cord-024076-q9fw7ch1	36	8	those	those	DT
cord-024076-q9fw7ch1	36	9	with	with	IN
cord-024076-q9fw7ch1	36	10	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	36	11	disease	disease	NN
cord-024076-q9fw7ch1	36	12	,	,	,
cord-024076-q9fw7ch1	36	13	hypertension	hypertension	NN
cord-024076-q9fw7ch1	36	14	,	,	,
cord-024076-q9fw7ch1	36	15	heart	heart	NN
cord-024076-q9fw7ch1	36	16	failure	failure	NN
cord-024076-q9fw7ch1	36	17	with	with	IN
cord-024076-q9fw7ch1	36	18	reduced	reduce	VBN
cord-024076-q9fw7ch1	36	19	ejection	ejection	NN
cord-024076-q9fw7ch1	36	20	fraction	fraction	NN
cord-024076-q9fw7ch1	36	21	(	(	-LRB-
cord-024076-q9fw7ch1	36	22	HFrEF	HFrEF	NNP
cord-024076-q9fw7ch1	36	23	)	)	-RRB-
cord-024076-q9fw7ch1	36	24	,	,	,
cord-024076-q9fw7ch1	36	25	and	and	CC
cord-024076-q9fw7ch1	36	26	diabetes	diabetes	NN
cord-024076-q9fw7ch1	36	27	with	with	IN
cord-024076-q9fw7ch1	36	28	chronic	chronic	JJ
cord-024076-q9fw7ch1	36	29	kidney	kidney	NN
cord-024076-q9fw7ch1	36	30	disease	disease	NN
cord-024076-q9fw7ch1	36	31	(	(	-LRB-
cord-024076-q9fw7ch1	36	32	DCKD	DCKD	NNP
cord-024076-q9fw7ch1	36	33	)	)	-RRB-
cord-024076-q9fw7ch1	36	34	on	on	IN
cord-024076-q9fw7ch1	36	35	ACE	ACE	NNP
cord-024076-q9fw7ch1	36	36	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	36	37	or	or	CC
cord-024076-q9fw7ch1	36	38	ARB	ARB	NNP
cord-024076-q9fw7ch1	36	39	treatment	treatment	NN
cord-024076-q9fw7ch1	36	40	and	and	CC
cord-024076-q9fw7ch1	36	41	an	an	DT
cord-024076-q9fw7ch1	36	42	increased	increase	VBN
cord-024076-q9fw7ch1	36	43	risk	risk	NN
cord-024076-q9fw7ch1	36	44	of	of	IN
cord-024076-q9fw7ch1	36	45	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	36	46	does	do	VBZ
cord-024076-q9fw7ch1	36	47	not	not	RB
cord-024076-q9fw7ch1	36	48	exist	exist	VB
cord-024076-q9fw7ch1	36	49	.	.	.
cord-024076-q9fw7ch1	37	1	There	there	EX
cord-024076-q9fw7ch1	37	2	are	be	VBP
cord-024076-q9fw7ch1	37	3	alternative	alternative	JJ
cord-024076-q9fw7ch1	37	4	agents	agent	NNS
cord-024076-q9fw7ch1	37	5	that	that	WDT
cord-024076-q9fw7ch1	37	6	can	can	MD
cord-024076-q9fw7ch1	37	7	be	be	VB
cord-024076-q9fw7ch1	37	8	used	use	VBN
cord-024076-q9fw7ch1	37	9	for	for	IN
cord-024076-q9fw7ch1	37	10	the	the	DT
cord-024076-q9fw7ch1	37	11	management	management	NN
cord-024076-q9fw7ch1	37	12	of	of	IN
cord-024076-q9fw7ch1	37	13	hypertension	hypertension	NN
cord-024076-q9fw7ch1	37	14	,	,	,
cord-024076-q9fw7ch1	37	15	but	but	CC
cord-024076-q9fw7ch1	37	16	DCKD	DCKD	NNP
cord-024076-q9fw7ch1	37	17	and	and	CC
cord-024076-q9fw7ch1	37	18	HFrEF	HFrEF	NNP
cord-024076-q9fw7ch1	37	19	are	be	VBP
cord-024076-q9fw7ch1	37	20	compelling	compelling	JJ
cord-024076-q9fw7ch1	37	21	indications	indication	NNS
cord-024076-q9fw7ch1	37	22	for	for	IN
cord-024076-q9fw7ch1	37	23	these	these	DT
cord-024076-q9fw7ch1	37	24	drugs	drug	NNS
cord-024076-q9fw7ch1	37	25	.	.	.
cord-024076-q9fw7ch1	38	1	Patients	patient	NNS
cord-024076-q9fw7ch1	38	2	,	,	,
cord-024076-q9fw7ch1	38	3	influenced	influence	VBN
cord-024076-q9fw7ch1	38	4	by	by	IN
cord-024076-q9fw7ch1	38	5	the	the	DT
cord-024076-q9fw7ch1	38	6	media	medium	NNS
cord-024076-q9fw7ch1	38	7	,	,	,
cord-024076-q9fw7ch1	38	8	may	may	MD
cord-024076-q9fw7ch1	38	9	request	request	VB
cord-024076-q9fw7ch1	38	10	an	an	DT
cord-024076-q9fw7ch1	38	11	alternative	alternative	JJ
cord-024076-q9fw7ch1	38	12	anti	anti	JJ
cord-024076-q9fw7ch1	38	13	-	-	JJ
cord-024076-q9fw7ch1	38	14	hypertensive	hypertensive	JJ
cord-024076-q9fw7ch1	38	15	agent	agent	NN
cord-024076-q9fw7ch1	38	16	,	,	,
cord-024076-q9fw7ch1	38	17	and	and	CC
cord-024076-q9fw7ch1	38	18	that	that	DT
cord-024076-q9fw7ch1	38	19	may	may	MD
cord-024076-q9fw7ch1	38	20	be	be	VB
cord-024076-q9fw7ch1	38	21	appropriate	appropriate	JJ
cord-024076-q9fw7ch1	38	22	for	for	IN
cord-024076-q9fw7ch1	38	23	them	-PRON-	PRP
cord-024076-q9fw7ch1	38	24	,	,	,
cord-024076-q9fw7ch1	38	25	but	but	CC
cord-024076-q9fw7ch1	38	26	it	-PRON-	PRP
cord-024076-q9fw7ch1	38	27	is	be	VBZ
cord-024076-q9fw7ch1	38	28	inappropriate	inappropriate	JJ
cord-024076-q9fw7ch1	38	29	to	to	TO
cord-024076-q9fw7ch1	38	30	recommend	recommend	VB
cord-024076-q9fw7ch1	38	31	discontinuation	discontinuation	NN
cord-024076-q9fw7ch1	38	32	of	of	IN
cord-024076-q9fw7ch1	38	33	ACE	ace	NN
cord-024076-q9fw7ch1	38	34	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	38	35	or	or	CC
cord-024076-q9fw7ch1	38	36	ARB	arb	NN
cord-024076-q9fw7ch1	38	37	treatment	treatment	NN
cord-024076-q9fw7ch1	38	38	in	in	IN
cord-024076-q9fw7ch1	38	39	patients	patient	NNS
cord-024076-q9fw7ch1	38	40	with	with	IN
cord-024076-q9fw7ch1	38	41	HFrEF	HFrEF	NNP
cord-024076-q9fw7ch1	38	42	and	and	CC
cord-024076-q9fw7ch1	38	43	DCKD	DCKD	NNP
cord-024076-q9fw7ch1	38	44	based	base	VBN
cord-024076-q9fw7ch1	38	45	on	on	IN
cord-024076-q9fw7ch1	38	46	a	a	DT
cord-024076-q9fw7ch1	38	47	hypothetical	hypothetical	JJ
cord-024076-q9fw7ch1	38	48	adverse	adverse	JJ
cord-024076-q9fw7ch1	38	49	outcome	outcome	NN
cord-024076-q9fw7ch1	38	50	with	with	IN
cord-024076-q9fw7ch1	38	51	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	38	52	infection	infection	NN
cord-024076-q9fw7ch1	38	53	.	.	.
cord-024076-q9fw7ch1	39	1	Importantly	importantly	RB
cord-024076-q9fw7ch1	39	2	,	,	,
cord-024076-q9fw7ch1	39	3	the	the	DT
cord-024076-q9fw7ch1	39	4	indication	indication	NN
cord-024076-q9fw7ch1	39	5	for	for	IN
cord-024076-q9fw7ch1	39	6	which	which	WDT
cord-024076-q9fw7ch1	39	7	the	the	DT
cord-024076-q9fw7ch1	39	8	drugs	drug	NNS
cord-024076-q9fw7ch1	39	9	were	be	VBD
cord-024076-q9fw7ch1	39	10	originally	originally	RB
cord-024076-q9fw7ch1	39	11	prescribed	prescribe	VBN
cord-024076-q9fw7ch1	39	12	may	may	MD
cord-024076-q9fw7ch1	39	13	have	have	VB
cord-024076-q9fw7ch1	39	14	changed	change	VBN
cord-024076-q9fw7ch1	39	15	since	since	IN
cord-024076-q9fw7ch1	39	16	the	the	DT
cord-024076-q9fw7ch1	39	17	drugs	drug	NNS
cord-024076-q9fw7ch1	39	18	were	be	VBD
cord-024076-q9fw7ch1	39	19	initiated	initiate	VBN
cord-024076-q9fw7ch1	39	20	,	,	,
cord-024076-q9fw7ch1	39	21	and	and	CC
cord-024076-q9fw7ch1	39	22	a	a	DT
cord-024076-q9fw7ch1	39	23	patient	patient	NN
cord-024076-q9fw7ch1	39	24	with	with	IN
cord-024076-q9fw7ch1	39	25	hypertension	hypertension	NN
cord-024076-q9fw7ch1	39	26	may	may	MD
cord-024076-q9fw7ch1	39	27	not	not	RB
cord-024076-q9fw7ch1	39	28	be	be	VB
cord-024076-q9fw7ch1	39	29	aware	aware	JJ
cord-024076-q9fw7ch1	39	30	of	of	IN
cord-024076-q9fw7ch1	39	31	that	that	DT
cord-024076-q9fw7ch1	39	32	they	-PRON-	PRP
cord-024076-q9fw7ch1	39	33	have	have	VBP
cord-024076-q9fw7ch1	39	34	developed	develop	VBN
cord-024076-q9fw7ch1	39	35	LV	LV	NNP
cord-024076-q9fw7ch1	39	36	systolic	systolic	JJ
cord-024076-q9fw7ch1	39	37	dysfunction	dysfunction	NN
cord-024076-q9fw7ch1	39	38	or	or	CC
cord-024076-q9fw7ch1	39	39	that	that	IN
cord-024076-q9fw7ch1	39	40	a	a	DT
cord-024076-q9fw7ch1	39	41	diabetic	diabetic	NN
cord-024076-q9fw7ch1	39	42	has	have	VBZ
cord-024076-q9fw7ch1	39	43	developed	develop	VBN
cord-024076-q9fw7ch1	39	44	proteinuria	proteinuria	NN
cord-024076-q9fw7ch1	39	45	.	.	.
cord-024076-q9fw7ch1	40	1	A	a	DT
cord-024076-q9fw7ch1	40	2	recent	recent	JJ
cord-024076-q9fw7ch1	40	3	report	report	NN
cord-024076-q9fw7ch1	40	4	suggested	suggest	VBD
cord-024076-q9fw7ch1	40	5	a	a	DT
cord-024076-q9fw7ch1	40	6	reverse	reverse	JJ
cord-024076-q9fw7ch1	40	7	causality	causality	NN
cord-024076-q9fw7ch1	40	8	relationship	relationship	NN
cord-024076-q9fw7ch1	40	9	by	by	IN
cord-024076-q9fw7ch1	40	10	the	the	DT
cord-024076-q9fw7ch1	40	11	fact	fact	NN
cord-024076-q9fw7ch1	40	12	that	that	IN
cord-024076-q9fw7ch1	40	13	patients	patient	NNS
cord-024076-q9fw7ch1	40	14	who	who	WP
cord-024076-q9fw7ch1	40	15	are	be	VBP
cord-024076-q9fw7ch1	40	16	receiving	receive	VBG
cord-024076-q9fw7ch1	40	17	ACE	ACE	NNP
cord-024076-q9fw7ch1	40	18	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	40	19	or	or	CC
cord-024076-q9fw7ch1	40	20	ARB	ARB	NNP
cord-024076-q9fw7ch1	40	21	may	may	MD
cord-024076-q9fw7ch1	40	22	be	be	VB
cord-024076-q9fw7ch1	40	23	more	more	RBR
cord-024076-q9fw7ch1	40	24	susceptible	susceptible	JJ
cord-024076-q9fw7ch1	40	25	to	to	IN
cord-024076-q9fw7ch1	40	26	viral	viral	JJ
cord-024076-q9fw7ch1	40	27	infections	infection	NNS
cord-024076-q9fw7ch1	40	28	and	and	CC
cord-024076-q9fw7ch1	40	29	more	more	RBR
cord-024076-q9fw7ch1	40	30	likely	likely	JJ
cord-024076-q9fw7ch1	40	31	to	to	TO
cord-024076-q9fw7ch1	40	32	have	have	VB
cord-024076-q9fw7ch1	40	33	a	a	DT
cord-024076-q9fw7ch1	40	34	higher	high	JJR
cord-024076-q9fw7ch1	40	35	risk	risk	NN
cord-024076-q9fw7ch1	40	36	of	of	IN
cord-024076-q9fw7ch1	40	37	dying	die	VBG
cord-024076-q9fw7ch1	40	38	because	because	IN
cord-024076-q9fw7ch1	40	39	they	-PRON-	PRP
cord-024076-q9fw7ch1	40	40	are	be	VBP
cord-024076-q9fw7ch1	40	41	older	old	JJR
cord-024076-q9fw7ch1	40	42	and	and	CC
cord-024076-q9fw7ch1	40	43	hence	hence	RB
cord-024076-q9fw7ch1	40	44	would	would	MD
cord-024076-q9fw7ch1	40	45	have	have	VB
cord-024076-q9fw7ch1	40	46	a	a	DT
cord-024076-q9fw7ch1	40	47	higher	high	JJR
cord-024076-q9fw7ch1	40	48	prevalence	prevalence	NN
cord-024076-q9fw7ch1	40	49	of	of	IN
cord-024076-q9fw7ch1	40	50	hypertension	hypertension	NN
cord-024076-q9fw7ch1	40	51	,	,	,
cord-024076-q9fw7ch1	40	52	renal	renal	JJ
cord-024076-q9fw7ch1	40	53	disease	disease	NN
cord-024076-q9fw7ch1	40	54	and	and	CC
cord-024076-q9fw7ch1	40	55	diabetes	diabetes	NN
cord-024076-q9fw7ch1	40	56	.	.	.
cord-024076-q9fw7ch1	41	1	(	(	-LRB-
cord-024076-q9fw7ch1	41	2	11	11	CD
cord-024076-q9fw7ch1	41	3	)	)	-RRB-
cord-024076-q9fw7ch1	42	1	It	-PRON-	PRP
cord-024076-q9fw7ch1	42	2	is	be	VBZ
cord-024076-q9fw7ch1	42	3	important	important	JJ
cord-024076-q9fw7ch1	42	4	to	to	TO
cord-024076-q9fw7ch1	42	5	recognize	recognize	VB
cord-024076-q9fw7ch1	42	6	that	that	IN
cord-024076-q9fw7ch1	42	7	pathophysiological	pathophysiological	JJ
cord-024076-q9fw7ch1	42	8	mechanisms	mechanism	NNS
cord-024076-q9fw7ch1	42	9	that	that	WDT
cord-024076-q9fw7ch1	42	10	lead	lead	VBP
cord-024076-q9fw7ch1	42	11	to	to	IN
cord-024076-q9fw7ch1	42	12	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	42	13	disease	disease	NN
cord-024076-q9fw7ch1	42	14	are	be	VBP
cord-024076-q9fw7ch1	42	15	known	know	VBN
cord-024076-q9fw7ch1	42	16	to	to	TO
cord-024076-q9fw7ch1	42	17	overlap	overlap	VB
cord-024076-q9fw7ch1	42	18	with	with	IN
cord-024076-q9fw7ch1	42	19	pathways	pathway	NNS
cord-024076-q9fw7ch1	42	20	that	that	WDT
cord-024076-q9fw7ch1	42	21	regulate	regulate	VBP
cord-024076-q9fw7ch1	42	22	immunological	immunological	JJ
cord-024076-q9fw7ch1	42	23	functions	function	NNS
cord-024076-q9fw7ch1	42	24	.	.	.
cord-024076-q9fw7ch1	43	1	Thus	thus	RB
cord-024076-q9fw7ch1	43	2	,	,	,
cord-024076-q9fw7ch1	43	3	age	age	NN
cord-024076-q9fw7ch1	43	4	is	be	VBZ
cord-024076-q9fw7ch1	43	5	one	one	CD
cord-024076-q9fw7ch1	43	6	of	of	IN
cord-024076-q9fw7ch1	43	7	the	the	DT
cord-024076-q9fw7ch1	43	8	strongest	strong	JJS
cord-024076-q9fw7ch1	43	9	risk	risk	NN
cord-024076-q9fw7ch1	43	10	predictors	predictor	NNS
cord-024076-q9fw7ch1	43	11	for	for	IN
cord-024076-q9fw7ch1	43	12	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	43	13	disease	disease	NN
cord-024076-q9fw7ch1	43	14	and	and	CC
cord-024076-q9fw7ch1	43	15	the	the	DT
cord-024076-q9fw7ch1	43	16	effect	effect	NN
cord-024076-q9fw7ch1	43	17	of	of	IN
cord-024076-q9fw7ch1	43	18	ageing	age	VBG
cord-024076-q9fw7ch1	43	19	on	on	IN
cord-024076-q9fw7ch1	43	20	immune	immune	JJ
cord-024076-q9fw7ch1	43	21	function	function	NN
cord-024076-q9fw7ch1	43	22	may	may	MD
cord-024076-q9fw7ch1	43	23	be	be	VB
cord-024076-q9fw7ch1	43	24	equally	equally	RB
cord-024076-q9fw7ch1	43	25	important	important	JJ
cord-024076-q9fw7ch1	43	26	for	for	IN
cord-024076-q9fw7ch1	43	27	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	43	28	susceptibility	susceptibility	NN
cord-024076-q9fw7ch1	43	29	and	and	CC
cord-024076-q9fw7ch1	43	30	severity	severity	NN
cord-024076-q9fw7ch1	43	31	.	.	.
cord-024076-q9fw7ch1	44	1	(	(	-LRB-
cord-024076-q9fw7ch1	44	2	12	12	CD
cord-024076-q9fw7ch1	44	3	)	)	-RRB-
cord-024076-q9fw7ch1	45	1	A	a	DT
cord-024076-q9fw7ch1	45	2	dysregulated	dysregulated	JJ
cord-024076-q9fw7ch1	45	3	immunologic	immunologic	JJ
cord-024076-q9fw7ch1	45	4	state	state	NN
cord-024076-q9fw7ch1	45	5	corresponds	correspond	VBZ
cord-024076-q9fw7ch1	45	6	with	with	IN
cord-024076-q9fw7ch1	45	7	an	an	DT
cord-024076-q9fw7ch1	45	8	elevated	elevated	JJ
cord-024076-q9fw7ch1	45	9	risk	risk	NN
cord-024076-q9fw7ch1	45	10	of	of	IN
cord-024076-q9fw7ch1	45	11	incident	incident	NN
cord-024076-q9fw7ch1	45	12	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	45	13	disease	disease	NN
cord-024076-q9fw7ch1	45	14	and	and	CC
cord-024076-q9fw7ch1	45	15	thus	thus	RB
cord-024076-q9fw7ch1	45	16	other	other	JJ
cord-024076-q9fw7ch1	45	17	traditional	traditional	JJ
cord-024076-q9fw7ch1	45	18	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	45	19	disease	disease	NN
cord-024076-q9fw7ch1	45	20	risk	risk	NN
cord-024076-q9fw7ch1	45	21	factors	factor	NNS
cord-024076-q9fw7ch1	45	22	such	such	JJ
cord-024076-q9fw7ch1	45	23	as	as	IN
cord-024076-q9fw7ch1	45	24	diabetes	diabetes	NN
cord-024076-q9fw7ch1	45	25	and	and	CC
cord-024076-q9fw7ch1	45	26	hyperlipidaemia	hyperlipidaemia	NN
cord-024076-q9fw7ch1	45	27	impact	impact	NN
cord-024076-q9fw7ch1	45	28	immune	immune	JJ
cord-024076-q9fw7ch1	45	29	function	function	NN
cord-024076-q9fw7ch1	45	30	.	.	.
cord-024076-q9fw7ch1	46	1	(	(	-LRB-
cord-024076-q9fw7ch1	46	2	13	13	CD
cord-024076-q9fw7ch1	46	3	)	)	-RRB-
cord-024076-q9fw7ch1	47	1	Thus	thus	RB
cord-024076-q9fw7ch1	47	2	,	,	,
cord-024076-q9fw7ch1	47	3	the	the	DT
cord-024076-q9fw7ch1	47	4	presence	presence	NN
cord-024076-q9fw7ch1	47	5	of	of	IN
cord-024076-q9fw7ch1	47	6	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	47	7	disease	disease	NN
cord-024076-q9fw7ch1	47	8	may	may	MD
cord-024076-q9fw7ch1	47	9	be	be	VB
cord-024076-q9fw7ch1	47	10	a	a	DT
cord-024076-q9fw7ch1	47	11	marker	marker	NN
cord-024076-q9fw7ch1	47	12	of	of	IN
cord-024076-q9fw7ch1	47	13	accelerated	accelerated	JJ
cord-024076-q9fw7ch1	47	14	immunologic	immunologic	JJ
cord-024076-q9fw7ch1	47	15	ageing	ageing	NN
cord-024076-q9fw7ch1	47	16	/	/	SYM
cord-024076-q9fw7ch1	47	17	dysregulation	dysregulation	NN
cord-024076-q9fw7ch1	47	18	and	and	CC
cord-024076-q9fw7ch1	47	19	relate	relate	VBP
cord-024076-q9fw7ch1	47	20	indirectly	indirectly	RB
cord-024076-q9fw7ch1	47	21	to	to	TO
cord-024076-q9fw7ch1	47	22	COVID-19	covid-19	VB
cord-024076-q9fw7ch1	47	23	prognosis.(12	prognosis.(12	CD
cord-024076-q9fw7ch1	47	24	)	)	-RRB-
cord-024076-q9fw7ch1	48	1	In	in	IN
cord-024076-q9fw7ch1	48	2	South	South	NNP
cord-024076-q9fw7ch1	48	3	Africa	Africa	NNP
cord-024076-q9fw7ch1	48	4	,	,	,
cord-024076-q9fw7ch1	48	5	hypertension	hypertension	NN
cord-024076-q9fw7ch1	48	6	,	,	,
cord-024076-q9fw7ch1	48	7	HFrEF	HFrEF	NNP
cord-024076-q9fw7ch1	48	8	and	and	CC
cord-024076-q9fw7ch1	48	9	diabetes	diabete	NNS
cord-024076-q9fw7ch1	48	10	are	be	VBP
cord-024076-q9fw7ch1	48	11	common	common	JJ
cord-024076-q9fw7ch1	48	12	non	non	JJ
cord-024076-q9fw7ch1	48	13	-	-	JJ
cord-024076-q9fw7ch1	48	14	communicable	communicable	JJ
cord-024076-q9fw7ch1	48	15	diseases	disease	NNS
cord-024076-q9fw7ch1	48	16	,	,	,
cord-024076-q9fw7ch1	48	17	and	and	CC
cord-024076-q9fw7ch1	48	18	a	a	DT
cord-024076-q9fw7ch1	48	19	significant	significant	JJ
cord-024076-q9fw7ch1	48	20	proportion	proportion	NN
cord-024076-q9fw7ch1	48	21	of	of	IN
cord-024076-q9fw7ch1	48	22	patients	patient	NNS
cord-024076-q9fw7ch1	48	23	are	be	VBP
cord-024076-q9fw7ch1	48	24	being	be	VBG
cord-024076-q9fw7ch1	48	25	treated	treat	VBN
cord-024076-q9fw7ch1	48	26	with	with	IN
cord-024076-q9fw7ch1	48	27	generic	generic	JJ
cord-024076-q9fw7ch1	48	28	versions	version	NNS
cord-024076-q9fw7ch1	48	29	of	of	IN
cord-024076-q9fw7ch1	48	30	ACE	ace	NN
cord-024076-q9fw7ch1	48	31	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	48	32	or	or	CC
cord-024076-q9fw7ch1	48	33	ARBs	arb	NNS
cord-024076-q9fw7ch1	48	34	.	.	.
cord-024076-q9fw7ch1	49	1	There	there	EX
cord-024076-q9fw7ch1	49	2	is	be	VBZ
cord-024076-q9fw7ch1	49	3	extremely	extremely	RB
cord-024076-q9fw7ch1	49	4	strong	strong	JJ
cord-024076-q9fw7ch1	49	5	scientific	scientific	JJ
cord-024076-q9fw7ch1	49	6	evidence	evidence	NN
cord-024076-q9fw7ch1	49	7	for	for	IN
cord-024076-q9fw7ch1	49	8	the	the	DT
cord-024076-q9fw7ch1	49	9	benefit	benefit	NN
cord-024076-q9fw7ch1	49	10	of	of	IN
cord-024076-q9fw7ch1	49	11	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	49	12	inhibition	inhibition	NN
cord-024076-q9fw7ch1	49	13	in	in	IN
cord-024076-q9fw7ch1	49	14	patients	patient	NNS
cord-024076-q9fw7ch1	49	15	with	with	IN
cord-024076-q9fw7ch1	49	16	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	49	17	disease	disease	NN
cord-024076-q9fw7ch1	49	18	.	.	.
cord-024076-q9fw7ch1	50	1	In	in	IN
cord-024076-q9fw7ch1	50	2	patients	patient	NNS
cord-024076-q9fw7ch1	50	3	with	with	IN
cord-024076-q9fw7ch1	50	4	HFrEF	HFrEF	NNP
cord-024076-q9fw7ch1	50	5	,	,	,
cord-024076-q9fw7ch1	50	6	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	50	7	inhibition	inhibition	NN
cord-024076-q9fw7ch1	50	8	is	be	VBZ
cord-024076-q9fw7ch1	50	9	a	a	DT
cord-024076-q9fw7ch1	50	10	foundation	foundation	NN
cord-024076-q9fw7ch1	50	11	of	of	IN
cord-024076-q9fw7ch1	50	12	therapy	therapy	NN
cord-024076-q9fw7ch1	50	13	for	for	IN
cord-024076-q9fw7ch1	50	14	these	these	DT
cord-024076-q9fw7ch1	50	15	patients	patient	NNS
cord-024076-q9fw7ch1	50	16	.	.	.
cord-024076-q9fw7ch1	51	1	Discontinuation	discontinuation	NN
cord-024076-q9fw7ch1	51	2	of	of	IN
cord-024076-q9fw7ch1	51	3	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	51	4	inhibition	inhibition	NN
cord-024076-q9fw7ch1	51	5	in	in	IN
cord-024076-q9fw7ch1	51	6	patients	patient	NNS
cord-024076-q9fw7ch1	51	7	with	with	IN
cord-024076-q9fw7ch1	51	8	heart	heart	NN
cord-024076-q9fw7ch1	51	9	failure	failure	NN
cord-024076-q9fw7ch1	51	10	can	can	MD
cord-024076-q9fw7ch1	51	11	precipitate	precipitate	VB
cord-024076-q9fw7ch1	51	12	clinical	clinical	JJ
cord-024076-q9fw7ch1	51	13	deterioration	deterioration	NN
cord-024076-q9fw7ch1	51	14	and	and	CC
cord-024076-q9fw7ch1	51	15	may	may	MD
cord-024076-q9fw7ch1	51	16	be	be	VB
cord-024076-q9fw7ch1	51	17	associated	associate	VBN
cord-024076-q9fw7ch1	51	18	with	with	IN
cord-024076-q9fw7ch1	51	19	increased	increase	VBN
cord-024076-q9fw7ch1	51	20	mortality	mortality	NN
cord-024076-q9fw7ch1	51	21	.	.	.
cord-024076-q9fw7ch1	52	1	(	(	-LRB-
cord-024076-q9fw7ch1	52	2	14	14	CD
cord-024076-q9fw7ch1	52	3	)	)	-RRB-
cord-024076-q9fw7ch1	53	1	Furthermore	furthermore	RB
cord-024076-q9fw7ch1	53	2	,	,	,
cord-024076-q9fw7ch1	53	3	ACE	ACE	NNP
cord-024076-q9fw7ch1	53	4	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	53	5	and	and	CC
cord-024076-q9fw7ch1	53	6	ARBs	arb	NNS
cord-024076-q9fw7ch1	53	7	are	be	VBP
cord-024076-q9fw7ch1	53	8	common	common	JJ
cord-024076-q9fw7ch1	53	9	therapies	therapy	NNS
cord-024076-q9fw7ch1	53	10	for	for	IN
cord-024076-q9fw7ch1	53	11	hypertension	hypertension	NN
cord-024076-q9fw7ch1	53	12	and	and	CC
cord-024076-q9fw7ch1	53	13	after	after	IN
cord-024076-q9fw7ch1	53	14	myocardial	myocardial	JJ
cord-024076-q9fw7ch1	53	15	infarction	infarction	NN
cord-024076-q9fw7ch1	53	16	.	.	.
cord-024076-q9fw7ch1	54	1	(	(	-LRB-
cord-024076-q9fw7ch1	54	2	15	15	CD
cord-024076-q9fw7ch1	54	3	,	,	,
cord-024076-q9fw7ch1	54	4	16	16	CD
cord-024076-q9fw7ch1	54	5	)	)	-RRB-
cord-024076-q9fw7ch1	55	1	There	there	EX
cord-024076-q9fw7ch1	55	2	is	be	VBZ
cord-024076-q9fw7ch1	55	3	significant	significant	JJ
cord-024076-q9fw7ch1	55	4	mortality	mortality	NN
cord-024076-q9fw7ch1	55	5	benefit	benefit	NN
cord-024076-q9fw7ch1	55	6	with	with	IN
cord-024076-q9fw7ch1	55	7	all	all	DT
cord-024076-q9fw7ch1	55	8	three	three	CD
cord-024076-q9fw7ch1	55	9	classes	class	NNS
cord-024076-q9fw7ch1	55	10	of	of	IN
cord-024076-q9fw7ch1	55	11	these	these	DT
cord-024076-q9fw7ch1	55	12	agents	agent	NNS
cord-024076-q9fw7ch1	55	13	'	'	POS
cord-024076-q9fw7ch1	55	14	post	post	JJ
cord-024076-q9fw7ch1	55	15	myocardial	myocardial	JJ
cord-024076-q9fw7ch1	55	16	infarction	infarction	NN
cord-024076-q9fw7ch1	55	17	.	.	.
cord-024076-q9fw7ch1	56	1	Based	base	VBN
cord-024076-q9fw7ch1	56	2	on	on	IN
cord-024076-q9fw7ch1	56	3	the	the	DT
cord-024076-q9fw7ch1	56	4	solid	solid	JJ
cord-024076-q9fw7ch1	56	5	scientific	scientific	JJ
cord-024076-q9fw7ch1	56	6	foundation	foundation	NN
cord-024076-q9fw7ch1	56	7	of	of	IN
cord-024076-q9fw7ch1	56	8	these	these	DT
cord-024076-q9fw7ch1	56	9	three	three	CD
cord-024076-q9fw7ch1	56	10	agents	agent	NNS
cord-024076-q9fw7ch1	56	11	in	in	IN
cord-024076-q9fw7ch1	56	12	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	56	13	disease	disease	NN
cord-024076-q9fw7ch1	56	14	,	,	,
cord-024076-q9fw7ch1	56	15	diabetes	diabetes	NN
cord-024076-q9fw7ch1	56	16	and	and	CC
cord-024076-q9fw7ch1	56	17	renal	renal	JJ
cord-024076-q9fw7ch1	56	18	disease	disease	NN
cord-024076-q9fw7ch1	56	19	,	,	,
cord-024076-q9fw7ch1	56	20	there	there	EX
cord-024076-q9fw7ch1	56	21	is	be	VBZ
cord-024076-q9fw7ch1	56	22	a	a	DT
cord-024076-q9fw7ch1	56	23	potential	potential	NN
cord-024076-q9fw7ch1	56	24	for	for	IN
cord-024076-q9fw7ch1	56	25	significant	significant	JJ
cord-024076-q9fw7ch1	56	26	adverse	adverse	JJ
cord-024076-q9fw7ch1	56	27	outcomes	outcome	NNS
cord-024076-q9fw7ch1	56	28	in	in	IN
cord-024076-q9fw7ch1	56	29	discontinuing	discontinue	VBG
cord-024076-q9fw7ch1	56	30	these	these	DT
cord-024076-q9fw7ch1	56	31	agents	agent	NNS
cord-024076-q9fw7ch1	56	32	.	.	.
cord-024076-q9fw7ch1	57	1	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	57	2	appears	appear	VBZ
cord-024076-q9fw7ch1	57	3	to	to	TO
cord-024076-q9fw7ch1	57	4	be	be	VB
cord-024076-q9fw7ch1	57	5	particularly	particularly	RB
cord-024076-q9fw7ch1	57	6	severe	severe	JJ
cord-024076-q9fw7ch1	57	7	in	in	IN
cord-024076-q9fw7ch1	57	8	patients	patient	NNS
cord-024076-q9fw7ch1	57	9	with	with	IN
cord-024076-q9fw7ch1	57	10	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	57	11	disease	disease	NN
cord-024076-q9fw7ch1	57	12	and	and	CC
cord-024076-q9fw7ch1	57	13	may	may	MD
cord-024076-q9fw7ch1	57	14	cause	cause	VB
cord-024076-q9fw7ch1	57	15	myocarditis	myocarditis	NN
cord-024076-q9fw7ch1	57	16	,	,	,
cord-024076-q9fw7ch1	57	17	myocardial	myocardial	JJ
cord-024076-q9fw7ch1	57	18	stress	stress	NN
cord-024076-q9fw7ch1	57	19	and	and	CC
cord-024076-q9fw7ch1	57	20	cardiomyopathy.(12	cardiomyopathy.(12	NN
cord-024076-q9fw7ch1	57	21	)	)	-RRB-
cord-024076-q9fw7ch1	58	1	Thus	thus	RB
cord-024076-q9fw7ch1	58	2	,	,	,
cord-024076-q9fw7ch1	58	3	discontinuing	discontinue	VBG
cord-024076-q9fw7ch1	58	4	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	58	5	inhibition	inhibition	NN
cord-024076-q9fw7ch1	58	6	in	in	IN
cord-024076-q9fw7ch1	58	7	these	these	DT
cord-024076-q9fw7ch1	58	8	high	high	JJ
cord-024076-q9fw7ch1	58	9	-	-	HYPH
cord-024076-q9fw7ch1	58	10	risk	risk	NN
cord-024076-q9fw7ch1	58	11	patients	patient	NNS
cord-024076-q9fw7ch1	58	12	can	can	MD
cord-024076-q9fw7ch1	58	13	potentially	potentially	RB
cord-024076-q9fw7ch1	58	14	lead	lead	VB
cord-024076-q9fw7ch1	58	15	to	to	IN
cord-024076-q9fw7ch1	58	16	higher	high	JJR
cord-024076-q9fw7ch1	58	17	mortality	mortality	NN
cord-024076-q9fw7ch1	58	18	.	.	.
cord-024076-q9fw7ch1	59	1	Change	change	NN
cord-024076-q9fw7ch1	59	2	of	of	IN
cord-024076-q9fw7ch1	59	3	therapy	therapy	NN
cord-024076-q9fw7ch1	59	4	for	for	IN
cord-024076-q9fw7ch1	59	5	patients	patient	NNS
cord-024076-q9fw7ch1	59	6	with	with	IN
cord-024076-q9fw7ch1	59	7	hypertension	hypertension	NN
cord-024076-q9fw7ch1	59	8	is	be	VBZ
cord-024076-q9fw7ch1	59	9	less	less	RBR
cord-024076-q9fw7ch1	59	10	risky	risky	JJ
cord-024076-q9fw7ch1	59	11	.	.	.
cord-024076-q9fw7ch1	60	1	However	however	RB
cord-024076-q9fw7ch1	60	2	,	,	,
cord-024076-q9fw7ch1	60	3	they	-PRON-	PRP
cord-024076-q9fw7ch1	60	4	are	be	VBP
cord-024076-q9fw7ch1	60	5	associated	associate	VBN
cord-024076-q9fw7ch1	60	6	with	with	IN
cord-024076-q9fw7ch1	60	7	other	other	JJ
cord-024076-q9fw7ch1	60	8	risks	risk	NNS
cord-024076-q9fw7ch1	60	9	such	such	JJ
cord-024076-q9fw7ch1	60	10	as	as	IN
cord-024076-q9fw7ch1	60	11	medication	medication	NN
cord-024076-q9fw7ch1	60	12	errors	error	NNS
cord-024076-q9fw7ch1	60	13	,	,	,
cord-024076-q9fw7ch1	60	14	rebound	rebound	VB
cord-024076-q9fw7ch1	60	15	increase	increase	NN
cord-024076-q9fw7ch1	60	16	in	in	IN
cord-024076-q9fw7ch1	60	17	blood	blood	NN
cord-024076-q9fw7ch1	60	18	pressure	pressure	NN
cord-024076-q9fw7ch1	60	19	,	,	,
cord-024076-q9fw7ch1	60	20	frequent	frequent	JJ
cord-024076-q9fw7ch1	60	21	monitoring	monitoring	NN
cord-024076-q9fw7ch1	60	22	to	to	TO
cord-024076-q9fw7ch1	60	23	assess	assess	VB
cord-024076-q9fw7ch1	60	24	adequate	adequate	JJ
cord-024076-q9fw7ch1	60	25	blood	blood	NN
cord-024076-q9fw7ch1	60	26	pressure	pressure	NN
cord-024076-q9fw7ch1	60	27	control	control	NN
cord-024076-q9fw7ch1	60	28	and	and	CC
cord-024076-q9fw7ch1	60	29	management	management	NN
cord-024076-q9fw7ch1	60	30	of	of	IN
cord-024076-q9fw7ch1	60	31	side	side	JJ
cord-024076-q9fw7ch1	60	32	effects	effect	NNS
cord-024076-q9fw7ch1	60	33	of	of	IN
cord-024076-q9fw7ch1	60	34	newly	newly	RB
cord-024076-q9fw7ch1	60	35	prescribed	prescribe	VBN
cord-024076-q9fw7ch1	60	36	medications	medication	NNS
cord-024076-q9fw7ch1	60	37	.	.	.
cord-024076-q9fw7ch1	61	1	It	-PRON-	PRP
cord-024076-q9fw7ch1	61	2	has	have	VBZ
cord-024076-q9fw7ch1	61	3	been	be	VBN
cord-024076-q9fw7ch1	61	4	shown	show	VBN
cord-024076-q9fw7ch1	61	5	that	that	IN
cord-024076-q9fw7ch1	61	6	even	even	RB
cord-024076-q9fw7ch1	61	7	short	short	JJ
cord-024076-q9fw7ch1	61	8	periods	period	NNS
cord-024076-q9fw7ch1	61	9	of	of	IN
cord-024076-q9fw7ch1	61	10	loss	loss	NN
cord-024076-q9fw7ch1	61	11	of	of	IN
cord-024076-q9fw7ch1	61	12	control	control	NN
cord-024076-q9fw7ch1	61	13	of	of	IN
cord-024076-q9fw7ch1	61	14	blood	blood	NN
cord-024076-q9fw7ch1	61	15	pressure	pressure	NN
cord-024076-q9fw7ch1	61	16	may	may	MD
cord-024076-q9fw7ch1	61	17	be	be	VB
cord-024076-q9fw7ch1	61	18	associated	associate	VBN
cord-024076-q9fw7ch1	61	19	with	with	IN
cord-024076-q9fw7ch1	61	20	increased	increase	VBN
cord-024076-q9fw7ch1	61	21	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	61	22	risk	risk	NN
cord-024076-q9fw7ch1	61	23	.	.	.
cord-024076-q9fw7ch1	62	1	(	(	-LRB-
cord-024076-q9fw7ch1	62	2	17	17	CD
cord-024076-q9fw7ch1	62	3	)	)	-RRB-
cord-024076-q9fw7ch1	63	1	In	in	IN
cord-024076-q9fw7ch1	63	2	response	response	NN
cord-024076-q9fw7ch1	63	3	to	to	IN
cord-024076-q9fw7ch1	63	4	the	the	DT
cord-024076-q9fw7ch1	63	5	reports	report	NNS
cord-024076-q9fw7ch1	63	6	of	of	IN
cord-024076-q9fw7ch1	63	7	a	a	DT
cord-024076-q9fw7ch1	63	8	hypothetical	hypothetical	JJ
cord-024076-q9fw7ch1	63	9	risk	risk	NN
cord-024076-q9fw7ch1	63	10	of	of	IN
cord-024076-q9fw7ch1	63	11	ACE	ace	NN
cord-024076-q9fw7ch1	63	12	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	63	13	and	and	CC
cord-024076-q9fw7ch1	63	14	ARBs	arb	NNS
cord-024076-q9fw7ch1	63	15	,	,	,
cord-024076-q9fw7ch1	63	16	many	many	JJ
cord-024076-q9fw7ch1	63	17	societies	society	NNS
cord-024076-q9fw7ch1	63	18	have	have	VBP
cord-024076-q9fw7ch1	63	19	issued	issue	VBN
cord-024076-q9fw7ch1	63	20	statements	statement	NNS
cord-024076-q9fw7ch1	63	21	strongly	strongly	RB
cord-024076-q9fw7ch1	63	22	recommending	recommend	VBG
cord-024076-q9fw7ch1	63	23	the	the	DT
cord-024076-q9fw7ch1	63	24	continuation	continuation	NN
cord-024076-q9fw7ch1	63	25	of	of	IN
cord-024076-q9fw7ch1	63	26	ACE	ACE	NNP
cord-024076-q9fw7ch1	63	27	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	63	28	and	and	CC
cord-024076-q9fw7ch1	63	29	ARB	arb	NN
cord-024076-q9fw7ch1	63	30	therapies	therapy	NNS
cord-024076-q9fw7ch1	63	31	.	.	.
cord-024076-q9fw7ch1	64	1	(	(	-LRB-
cord-024076-q9fw7ch1	64	2	18	18	CD
cord-024076-q9fw7ch1	64	3	,	,	,
cord-024076-q9fw7ch1	64	4	19	19	CD
cord-024076-q9fw7ch1	64	5	)	)	-RRB-
cord-024076-q9fw7ch1	64	6	Patients	patient	NNS
cord-024076-q9fw7ch1	64	7	are	be	VBP
cord-024076-q9fw7ch1	64	8	strongly	strongly	RB
cord-024076-q9fw7ch1	64	9	discouraged	discouraged	JJ
cord-024076-q9fw7ch1	64	10	from	from	IN
cord-024076-q9fw7ch1	64	11	making	make	VBG
cord-024076-q9fw7ch1	64	12	autonomous	autonomous	JJ
cord-024076-q9fw7ch1	64	13	decisions	decision	NNS
cord-024076-q9fw7ch1	64	14	about	about	IN
cord-024076-q9fw7ch1	64	15	their	-PRON-	PRP$
cord-024076-q9fw7ch1	64	16	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	64	17	therapy	therapy	NN
cord-024076-q9fw7ch1	64	18	and	and	CC
cord-024076-q9fw7ch1	64	19	must	must	MD
cord-024076-q9fw7ch1	64	20	be	be	VB
cord-024076-q9fw7ch1	64	21	guided	guide	VBN
cord-024076-q9fw7ch1	64	22	by	by	IN
cord-024076-q9fw7ch1	64	23	their	-PRON-	PRP$
cord-024076-q9fw7ch1	64	24	informed	inform	VBN
cord-024076-q9fw7ch1	64	25	treating	treat	VBG
cord-024076-q9fw7ch1	64	26	physician	physician	NN
cord-024076-q9fw7ch1	64	27	.	.	.
cord-024076-q9fw7ch1	65	1	Moving	move	VBG
cord-024076-q9fw7ch1	65	2	forward	forward	RB
cord-024076-q9fw7ch1	65	3	it	-PRON-	PRP
cord-024076-q9fw7ch1	65	4	is	be	VBZ
cord-024076-q9fw7ch1	65	5	clear	clear	JJ
cord-024076-q9fw7ch1	65	6	that	that	IN
cord-024076-q9fw7ch1	65	7	more	more	JJR
cord-024076-q9fw7ch1	65	8	research	research	NN
cord-024076-q9fw7ch1	65	9	is	be	VBZ
cord-024076-q9fw7ch1	65	10	needed	need	VBN
cord-024076-q9fw7ch1	65	11	to	to	TO
cord-024076-q9fw7ch1	65	12	clarify	clarify	VB
cord-024076-q9fw7ch1	65	13	and	and	CC
cord-024076-q9fw7ch1	65	14	understand	understand	VB
cord-024076-q9fw7ch1	65	15	the	the	DT
cord-024076-q9fw7ch1	65	16	relationship	relationship	NN
cord-024076-q9fw7ch1	65	17	between	between	IN
cord-024076-q9fw7ch1	65	18	the	the	DT
cord-024076-q9fw7ch1	65	19	ACE	ace	NN
cord-024076-q9fw7ch1	65	20	2	2	CD
cord-024076-q9fw7ch1	65	21	protein	protein	NN
cord-024076-q9fw7ch1	65	22	,	,	,
cord-024076-q9fw7ch1	65	23	ACE	ACE	NNP
cord-024076-q9fw7ch1	65	24	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	65	25	and	and	CC
cord-024076-q9fw7ch1	65	26	ARB	ARB	NNP
cord-024076-q9fw7ch1	65	27	use	use	NN
cord-024076-q9fw7ch1	65	28	in	in	IN
cord-024076-q9fw7ch1	65	29	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	65	30	disease	disease	NN
cord-024076-q9fw7ch1	65	31	and	and	CC
cord-024076-q9fw7ch1	65	32	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	65	33	prognosis	prognosis	NN
cord-024076-q9fw7ch1	65	34	.	.	.
cord-024076-q9fw7ch1	66	1	In	in	IN
cord-024076-q9fw7ch1	66	2	this	this	DT
cord-024076-q9fw7ch1	66	3	regard	regard	NN
cord-024076-q9fw7ch1	66	4	an	an	DT
cord-024076-q9fw7ch1	66	5	ongoing	ongoing	JJ
cord-024076-q9fw7ch1	66	6	randomized	randomized	JJ
cord-024076-q9fw7ch1	66	7	trial	trial	NN
cord-024076-q9fw7ch1	66	8	evaluating	evaluate	VBG
cord-024076-q9fw7ch1	66	9	recombinant	recombinant	JJ
cord-024076-q9fw7ch1	66	10	ACE	ACE	NNP
cord-024076-q9fw7ch1	66	11	2	2	CD
cord-024076-q9fw7ch1	66	12	in	in	IN
cord-024076-q9fw7ch1	66	13	the	the	DT
cord-024076-q9fw7ch1	66	14	setting	setting	NN
cord-024076-q9fw7ch1	66	15	of	of	IN
cord-024076-q9fw7ch1	66	16	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	66	17	may	may	MD
cord-024076-q9fw7ch1	66	18	help	help	VB
cord-024076-q9fw7ch1	66	19	one	one	CD
cord-024076-q9fw7ch1	66	20	to	to	TO
cord-024076-q9fw7ch1	66	21	provide	provide	VB
cord-024076-q9fw7ch1	66	22	mechanistic	mechanistic	JJ
cord-024076-q9fw7ch1	66	23	information	information	NN
cord-024076-q9fw7ch1	66	24	in	in	IN
cord-024076-q9fw7ch1	66	25	patients	patient	NNS
cord-024076-q9fw7ch1	66	26	infected	infect	VBN
cord-024076-q9fw7ch1	66	27	with	with	IN
cord-024076-q9fw7ch1	66	28	this	this	DT
cord-024076-q9fw7ch1	66	29	virus	virus	NN
cord-024076-q9fw7ch1	66	30	(	(	-LRB-
cord-024076-q9fw7ch1	66	31	ClinicalTrials.gov	ClinicalTrials.gov	NNP
cord-024076-q9fw7ch1	66	32	Identifier	Identifier	NNP
cord-024076-q9fw7ch1	66	33	:	:	:
cord-024076-q9fw7ch1	66	34	NCT04287686	NCT04287686	NNP
cord-024076-q9fw7ch1	66	35	)	)	-RRB-
cord-024076-q9fw7ch1	66	36	.	.	.
cord-024076-q9fw7ch1	67	1	(	(	-LRB-
cord-024076-q9fw7ch1	67	2	20	20	CD
cord-024076-q9fw7ch1	67	3	)	)	-RRB-
cord-024076-q9fw7ch1	68	1	This	this	DT
cord-024076-q9fw7ch1	68	2	therapy	therapy	NN
cord-024076-q9fw7ch1	68	3	has	have	VBZ
cord-024076-q9fw7ch1	68	4	the	the	DT
cord-024076-q9fw7ch1	68	5	possible	possible	JJ
cord-024076-q9fw7ch1	68	6	potential	potential	NN
cord-024076-q9fw7ch1	68	7	to	to	IN
cord-024076-q9fw7ch1	68	8	both	both	DT
cord-024076-q9fw7ch1	68	9	decrease	decrease	VB
cord-024076-q9fw7ch1	68	10	viral	viral	JJ
cord-024076-q9fw7ch1	68	11	load	load	NN
cord-024076-q9fw7ch1	68	12	and	and	CC
cord-024076-q9fw7ch1	68	13	ameliorate	ameliorate	VB
cord-024076-q9fw7ch1	68	14	the	the	DT
cord-024076-q9fw7ch1	68	15	harmful	harmful	JJ
cord-024076-q9fw7ch1	68	16	effects	effect	NNS
cord-024076-q9fw7ch1	68	17	of	of	IN
cord-024076-q9fw7ch1	68	18	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	68	19	II	II	NNP
cord-024076-q9fw7ch1	68	20	.	.	.
cord-024076-q9fw7ch1	69	1	Until	until	IN
cord-024076-q9fw7ch1	69	2	more	more	RBR
cord-024076-q9fw7ch1	69	3	robust	robust	JJ
cord-024076-q9fw7ch1	69	4	evidence	evidence	NN
cord-024076-q9fw7ch1	69	5	is	be	VBZ
cord-024076-q9fw7ch1	69	6	available	available	JJ
cord-024076-q9fw7ch1	69	7	,	,	,
cord-024076-q9fw7ch1	69	8	it	-PRON-	PRP
cord-024076-q9fw7ch1	69	9	is	be	VBZ
cord-024076-q9fw7ch1	69	10	prudent	prudent	JJ
cord-024076-q9fw7ch1	69	11	to	to	TO
cord-024076-q9fw7ch1	69	12	advise	advise	VB
cord-024076-q9fw7ch1	69	13	that	that	IN
cord-024076-q9fw7ch1	69	14	ACE	ace	NN
cord-024076-q9fw7ch1	69	15	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	69	16	or	or	CC
cord-024076-q9fw7ch1	69	17	ARB	arb	NN
cord-024076-q9fw7ch1	69	18	therapy	therapy	NN
cord-024076-q9fw7ch1	69	19	should	should	MD
cord-024076-q9fw7ch1	69	20	be	be	VB
cord-024076-q9fw7ch1	69	21	continued	continue	VBN
cord-024076-q9fw7ch1	69	22	in	in	IN
cord-024076-q9fw7ch1	69	23	patients	patient	NNS
cord-024076-q9fw7ch1	69	24	who	who	WP
cord-024076-q9fw7ch1	69	25	are	be	VBP
cord-024076-q9fw7ch1	69	26	at	at	IN
cord-024076-q9fw7ch1	69	27	risk	risk	NN
cord-024076-q9fw7ch1	69	28	for	for	IN
cord-024076-q9fw7ch1	69	29	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	69	30	infection	infection	NN
cord-024076-q9fw7ch1	69	31	or	or	CC
cord-024076-q9fw7ch1	69	32	who	who	WP
cord-024076-q9fw7ch1	69	33	have	have	VBP
cord-024076-q9fw7ch1	69	34	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	69	35	infection	infection	NN
cord-024076-q9fw7ch1	69	36	.	.	.
cord-024076-q9fw7ch1	70	1	Even	even	RB
cord-024076-q9fw7ch1	70	2	in	in	IN
cord-024076-q9fw7ch1	70	3	patients	patient	NNS
cord-024076-q9fw7ch1	70	4	with	with	IN
cord-024076-q9fw7ch1	70	5	current	current	JJ
cord-024076-q9fw7ch1	70	6	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	70	7	infection	infection	NN
cord-024076-q9fw7ch1	70	8	,	,	,
cord-024076-q9fw7ch1	70	9	ACE	ACE	NNP
cord-024076-q9fw7ch1	70	10	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	70	11	or	or	CC
cord-024076-q9fw7ch1	70	12	ARB	ARB	NNP
cord-024076-q9fw7ch1	70	13	should	should	MD
cord-024076-q9fw7ch1	70	14	be	be	VB
cord-024076-q9fw7ch1	70	15	initiated	initiate	VBN
cord-024076-q9fw7ch1	70	16	in	in	IN
cord-024076-q9fw7ch1	70	17	guideline	guideline	NN
cord-024076-q9fw7ch1	70	18	-	-	HYPH
cord-024076-q9fw7ch1	70	19	indicated	indicate	VBN
cord-024076-q9fw7ch1	70	20	conditions	condition	NNS
cord-024076-q9fw7ch1	70	21	such	such	JJ
cord-024076-q9fw7ch1	70	22	as	as	IN
cord-024076-q9fw7ch1	70	23	in	in	IN
cord-024076-q9fw7ch1	70	24	patients	patient	NNS
cord-024076-q9fw7ch1	70	25	with	with	IN
cord-024076-q9fw7ch1	70	26	heart	heart	NN
cord-024076-q9fw7ch1	70	27	failure	failure	NN
cord-024076-q9fw7ch1	70	28	or	or	CC
cord-024076-q9fw7ch1	70	29	myocardial	myocardial	JJ
cord-024076-q9fw7ch1	70	30	infarction	infarction	NN
cord-024076-q9fw7ch1	70	31	.	.	.
cord-024076-q9fw7ch1	71	1	We	-PRON-	PRP
cord-024076-q9fw7ch1	71	2	must	must	MD
cord-024076-q9fw7ch1	71	3	not	not	RB
cord-024076-q9fw7ch1	71	4	draw	draw	VB
cord-024076-q9fw7ch1	71	5	inappropriate	inappropriate	JJ
cord-024076-q9fw7ch1	71	6	conclusions	conclusion	NNS
cord-024076-q9fw7ch1	71	7	from	from	IN
cord-024076-q9fw7ch1	71	8	observational	observational	JJ
cord-024076-q9fw7ch1	71	9	studies	study	NNS
cord-024076-q9fw7ch1	71	10	.	.	.
cord-024076-q9fw7ch1	72	1	In	in	IN
cord-024076-q9fw7ch1	72	2	conclusion	conclusion	NN
cord-024076-q9fw7ch1	72	3	,	,	,
cord-024076-q9fw7ch1	72	4	in	in	IN
cord-024076-q9fw7ch1	72	5	the	the	DT
cord-024076-q9fw7ch1	72	6	current	current	JJ
cord-024076-q9fw7ch1	72	7	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	72	8	pandemic	pandemic	NN
cord-024076-q9fw7ch1	72	9	in	in	IN
cord-024076-q9fw7ch1	72	10	South	South	NNP
cord-024076-q9fw7ch1	72	11	Africa	Africa	NNP
cord-024076-q9fw7ch1	72	12	,	,	,
cord-024076-q9fw7ch1	72	13	both	both	DT
cord-024076-q9fw7ch1	72	14	practitioners	practitioner	NNS
cord-024076-q9fw7ch1	72	15	and	and	CC
cord-024076-q9fw7ch1	72	16	patients	patient	NNS
cord-024076-q9fw7ch1	72	17	need	need	VBP
cord-024076-q9fw7ch1	72	18	to	to	TO
cord-024076-q9fw7ch1	72	19	be	be	VB
cord-024076-q9fw7ch1	72	20	advised	advise	VBN
cord-024076-q9fw7ch1	72	21	that	that	IN
cord-024076-q9fw7ch1	72	22	ACE	ACE	NNP
cord-024076-q9fw7ch1	72	23	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	72	24	and	and	CC
cord-024076-q9fw7ch1	72	25	ARB	arb	NN
cord-024076-q9fw7ch1	72	26	therapy	therapy	NN
cord-024076-q9fw7ch1	72	27	should	should	MD
cord-024076-q9fw7ch1	72	28	be	be	VB
cord-024076-q9fw7ch1	72	29	continued	continue	VBN
cord-024076-q9fw7ch1	72	30	in	in	IN
cord-024076-q9fw7ch1	72	31	patients	patient	NNS
cord-024076-q9fw7ch1	72	32	with	with	IN
cord-024076-q9fw7ch1	72	33	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	72	34	disease	disease	NN
cord-024076-q9fw7ch1	72	35	and	and	CC
cord-024076-q9fw7ch1	72	36	in	in	IN
cord-024076-q9fw7ch1	72	37	associated	associated	JJ
cord-024076-q9fw7ch1	72	38	conditions	condition	NNS
cord-024076-q9fw7ch1	72	39	such	such	JJ
cord-024076-q9fw7ch1	72	40	as	as	IN
cord-024076-q9fw7ch1	72	41	diabetes	diabetes	NN
cord-024076-q9fw7ch1	72	42	and	and	CC
cord-024076-q9fw7ch1	72	43	renal	renal	JJ
cord-024076-q9fw7ch1	72	44	disease	disease	NN
cord-024076-q9fw7ch1	72	45	.	.	.
cord-024076-q9fw7ch1	73	1	Ongoing	ongoing	JJ
cord-024076-q9fw7ch1	73	2	research	research	NN
cord-024076-q9fw7ch1	73	3	efforts	effort	NNS
cord-024076-q9fw7ch1	73	4	need	need	VBP
cord-024076-q9fw7ch1	73	5	to	to	TO
cord-024076-q9fw7ch1	73	6	concentrate	concentrate	VB
cord-024076-q9fw7ch1	73	7	on	on	IN
cord-024076-q9fw7ch1	73	8	assessing	assess	VBG
cord-024076-q9fw7ch1	73	9	the	the	DT
cord-024076-q9fw7ch1	73	10	role	role	NN
cord-024076-q9fw7ch1	73	11	of	of	IN
cord-024076-q9fw7ch1	73	12	ACE	ACE	NNP
cord-024076-q9fw7ch1	73	13	2	2	CD
cord-024076-q9fw7ch1	73	14	in	in	IN
cord-024076-q9fw7ch1	73	15	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	73	16	infection	infection	NN
cord-024076-q9fw7ch1	73	17	and	and	CC
cord-024076-q9fw7ch1	73	18	the	the	DT
cord-024076-q9fw7ch1	73	19	effect	effect	NN
cord-024076-q9fw7ch1	73	20	on	on	IN
cord-024076-q9fw7ch1	73	21	mortality	mortality	NN
cord-024076-q9fw7ch1	73	22	of	of	IN
cord-024076-q9fw7ch1	73	23	known	know	VBN
cord-024076-q9fw7ch1	73	24	therapies	therapy	NNS
cord-024076-q9fw7ch1	73	25	for	for	IN
cord-024076-q9fw7ch1	73	26	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	73	27	disease	disease	NN
cord-024076-q9fw7ch1	73	28	such	such	JJ
cord-024076-q9fw7ch1	73	29	as	as	IN
cord-024076-q9fw7ch1	73	30	ACE	ace	NN
cord-024076-q9fw7ch1	73	31	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	73	32	and	and	CC
cord-024076-q9fw7ch1	73	33	ARBs	arb	NNS
cord-024076-q9fw7ch1	73	34	.	.	.
cord-024076-q9fw7ch1	74	1	It	-PRON-	PRP
cord-024076-q9fw7ch1	74	2	is	be	VBZ
cord-024076-q9fw7ch1	74	3	hoped	hope	VBN
cord-024076-q9fw7ch1	74	4	that	that	IN
cord-024076-q9fw7ch1	74	5	with	with	IN
cord-024076-q9fw7ch1	74	6	the	the	DT
cord-024076-q9fw7ch1	74	7	large	large	JJ
cord-024076-q9fw7ch1	74	8	numbers	number	NNS
cord-024076-q9fw7ch1	74	9	of	of	IN
cord-024076-q9fw7ch1	74	10	patients	patient	NNS
cord-024076-q9fw7ch1	74	11	currently	currently	RB
cord-024076-q9fw7ch1	74	12	infected	infect	VBN
cord-024076-q9fw7ch1	74	13	worldwide	worldwide	RB
cord-024076-q9fw7ch1	74	14	with	with	IN
cord-024076-q9fw7ch1	74	15	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	74	16	,	,	,
cord-024076-q9fw7ch1	74	17	this	this	DT
cord-024076-q9fw7ch1	74	18	information	information	NN
cord-024076-q9fw7ch1	74	19	will	will	MD
cord-024076-q9fw7ch1	74	20	be	be	VB
cord-024076-q9fw7ch1	74	21	elucidated	elucidate	VBN
cord-024076-q9fw7ch1	74	22	in	in	IN
cord-024076-q9fw7ch1	74	23	the	the	DT
cord-024076-q9fw7ch1	74	24	near	near	JJ
cord-024076-q9fw7ch1	74	25	future	future	NN
cord-024076-q9fw7ch1	74	26	.	.	.
cord-024076-q9fw7ch1	75	1	Preventing	prevent	VBG
cord-024076-q9fw7ch1	75	2	a	a	DT
cord-024076-q9fw7ch1	75	3	Covid-19	covid-19	NN
cord-024076-q9fw7ch1	75	4	pandemic	pandemic	NN
cord-024076-q9fw7ch1	75	5	:	:	:
cord-024076-q9fw7ch1	75	6	ACE	ace	NN
cord-024076-q9fw7ch1	75	7	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	75	8	as	as	IN
cord-024076-q9fw7ch1	75	9	a	a	DT
cord-024076-q9fw7ch1	75	10	potential	potential	JJ
cord-024076-q9fw7ch1	75	11	risk	risk	NN
cord-024076-q9fw7ch1	75	12	factor	factor	NN
cord-024076-q9fw7ch1	75	13	for	for	IN
cord-024076-q9fw7ch1	75	14	fatal	fatal	JJ
cord-024076-q9fw7ch1	75	15	Covid-19	covid-19	NN
cord-024076-q9fw7ch1	75	16	Are	be	VBP
cord-024076-q9fw7ch1	75	17	patients	patient	NNS
cord-024076-q9fw7ch1	75	18	with	with	IN
cord-024076-q9fw7ch1	75	19	hypertension	hypertension	NN
cord-024076-q9fw7ch1	75	20	and	and	CC
cord-024076-q9fw7ch1	75	21	diabetes	diabetes	NN
cord-024076-q9fw7ch1	75	22	mellitus	mellitus	NN
cord-024076-q9fw7ch1	75	23	at	at	IN
cord-024076-q9fw7ch1	75	24	increased	increase	VBN
cord-024076-q9fw7ch1	75	25	risk	risk	NN
cord-024076-q9fw7ch1	75	26	for	for	IN
cord-024076-q9fw7ch1	75	27	COVID-19	covid-19	JJ
cord-024076-q9fw7ch1	75	28	infection	infection	NN
cord-024076-q9fw7ch1	75	29	?	?	.
cord-024076-q9fw7ch1	76	1	Clinical	clinical	JJ
cord-024076-q9fw7ch1	76	2	characteristics	characteristic	NNS
cord-024076-q9fw7ch1	76	3	of	of	IN
cord-024076-q9fw7ch1	76	4	coronavirus	coronavirus	NN
cord-024076-q9fw7ch1	76	5	disease	disease	NN
cord-024076-q9fw7ch1	76	6	2019	2019	CD
cord-024076-q9fw7ch1	76	7	in	in	IN
cord-024076-q9fw7ch1	76	8	China	China	NNP
cord-024076-q9fw7ch1	76	9	Angiotensin	Angiotensin	NNP
cord-024076-q9fw7ch1	76	10	-	-	HYPH
cord-024076-q9fw7ch1	76	11	converting	convert	VBG
cord-024076-q9fw7ch1	76	12	enzyme	enzyme	NN
cord-024076-q9fw7ch1	76	13	2	2	CD
cord-024076-q9fw7ch1	76	14	is	be	VBZ
cord-024076-q9fw7ch1	76	15	a	a	DT
cord-024076-q9fw7ch1	76	16	functional	functional	JJ
cord-024076-q9fw7ch1	76	17	receptor	receptor	NN
cord-024076-q9fw7ch1	76	18	for	for	IN
cord-024076-q9fw7ch1	76	19	coronavirus	coronavirus	NN
cord-024076-q9fw7ch1	77	1	A	a	DT
cord-024076-q9fw7ch1	77	2	pneumonia	pneumonia	NN
cord-024076-q9fw7ch1	77	3	outbreak	outbreak	NN
cord-024076-q9fw7ch1	77	4	associated	associate	VBN
cord-024076-q9fw7ch1	77	5	with	with	IN
cord-024076-q9fw7ch1	77	6	a	a	DT
cord-024076-q9fw7ch1	77	7	new	new	JJ
cord-024076-q9fw7ch1	77	8	coronavirus	coronavirus	NN
cord-024076-q9fw7ch1	77	9	of	of	IN
cord-024076-q9fw7ch1	77	10	probable	probable	JJ
cord-024076-q9fw7ch1	77	11	bat	bat	NN
cord-024076-q9fw7ch1	77	12	origin	origin	NN
cord-024076-q9fw7ch1	77	13	Clinical	clinical	JJ
cord-024076-q9fw7ch1	77	14	and	and	CC
cord-024076-q9fw7ch1	77	15	biochemical	biochemical	JJ
cord-024076-q9fw7ch1	77	16	indexes	index	NNS
cord-024076-q9fw7ch1	77	17	from	from	IN
cord-024076-q9fw7ch1	77	18	2019-nCoV	2019-ncov	CD
cord-024076-q9fw7ch1	77	19	infected	infect	VBN
cord-024076-q9fw7ch1	77	20	patients	patient	NNS
cord-024076-q9fw7ch1	77	21	linked	link	VBN
cord-024076-q9fw7ch1	77	22	to	to	IN
cord-024076-q9fw7ch1	77	23	viral	viral	JJ
cord-024076-q9fw7ch1	77	24	loads	load	NNS
cord-024076-q9fw7ch1	77	25	and	and	CC
cord-024076-q9fw7ch1	77	26	lung	lung	NN
cord-024076-q9fw7ch1	77	27	injury	injury	NN
cord-024076-q9fw7ch1	77	28	Effect	Effect	NNP
cord-024076-q9fw7ch1	77	29	of	of	IN
cord-024076-q9fw7ch1	77	30	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	77	31	-	-	HYPH
cord-024076-q9fw7ch1	77	32	converting	convert	VBG
cord-024076-q9fw7ch1	77	33	-	-	HYPH
cord-024076-q9fw7ch1	77	34	enzyme	enzyme	NN
cord-024076-q9fw7ch1	77	35	inhibition	inhibition	NN
cord-024076-q9fw7ch1	77	36	and	and	CC
cord-024076-q9fw7ch1	77	37	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	77	38	II	ii	CD
cord-024076-q9fw7ch1	77	39	receptor	receptor	NN
cord-024076-q9fw7ch1	77	40	blockers	blocker	NNS
cord-024076-q9fw7ch1	77	41	on	on	IN
cord-024076-q9fw7ch1	77	42	cardiac	cardiac	JJ
cord-024076-q9fw7ch1	77	43	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	77	44	-	-	HYPH
cord-024076-q9fw7ch1	77	45	converting	convert	VBG
cord-024076-q9fw7ch1	77	46	enzyme	enzyme	NN
cord-024076-q9fw7ch1	77	47	2	2	CD
cord-024076-q9fw7ch1	77	48	Urinary	urinary	JJ
cord-024076-q9fw7ch1	77	49	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	77	50	-	-	HYPH
cord-024076-q9fw7ch1	77	51	converting	convert	VBG
cord-024076-q9fw7ch1	77	52	enzyme	enzyme	NN
cord-024076-q9fw7ch1	77	53	2	2	CD
cord-024076-q9fw7ch1	77	54	in	in	IN
cord-024076-q9fw7ch1	77	55	hypertensive	hypertensive	JJ
cord-024076-q9fw7ch1	77	56	patients	patient	NNS
cord-024076-q9fw7ch1	77	57	may	may	MD
cord-024076-q9fw7ch1	77	58	be	be	VB
cord-024076-q9fw7ch1	77	59	increased	increase	VBN
cord-024076-q9fw7ch1	77	60	by	by	IN
cord-024076-q9fw7ch1	77	61	olmesartan	olmesartan	NNP
cord-024076-q9fw7ch1	77	62	,	,	,
cord-024076-q9fw7ch1	77	63	an	an	DT
cord-024076-q9fw7ch1	77	64	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	77	65	II	II	NNP
cord-024076-q9fw7ch1	77	66	receptor	receptor	NN
cord-024076-q9fw7ch1	77	67	blocker	blocker	NN
cord-024076-q9fw7ch1	77	68	A	a	DT
cord-024076-q9fw7ch1	77	69	crucial	crucial	JJ
cord-024076-q9fw7ch1	77	70	role	role	NN
cord-024076-q9fw7ch1	77	71	of	of	IN
cord-024076-q9fw7ch1	77	72	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	77	73	converting	convert	VBG
cord-024076-q9fw7ch1	77	74	enzyme	enzyme	NN
cord-024076-q9fw7ch1	77	75	2	2	CD
cord-024076-q9fw7ch1	77	76	(	(	-LRB-
cord-024076-q9fw7ch1	77	77	ACE2	ACE2	NNP
cord-024076-q9fw7ch1	77	78	)	)	-RRB-
cord-024076-q9fw7ch1	77	79	in	in	IN
cord-024076-q9fw7ch1	77	80	SARS	SARS	NNP
cord-024076-q9fw7ch1	77	81	coronavirus	coronavirus	NN
cord-024076-q9fw7ch1	77	82	-	-	HYPH
cord-024076-q9fw7ch1	77	83	induced	induce	VBN
cord-024076-q9fw7ch1	77	84	lung	lung	NN
cord-024076-q9fw7ch1	77	85	injury	injury	NN
cord-024076-q9fw7ch1	77	86	Pathology	pathology	NN
cord-024076-q9fw7ch1	77	87	and	and	CC
cord-024076-q9fw7ch1	77	88	pathogenesis	pathogenesis	NN
cord-024076-q9fw7ch1	77	89	of	of	IN
cord-024076-q9fw7ch1	77	90	severe	severe	JJ
cord-024076-q9fw7ch1	77	91	acute	acute	JJ
cord-024076-q9fw7ch1	77	92	respiratory	respiratory	JJ
cord-024076-q9fw7ch1	77	93	syndrome	syndrome	NN
cord-024076-q9fw7ch1	77	94	SARS	SARS	NNP
cord-024076-q9fw7ch1	77	95	-	-	HYPH
cord-024076-q9fw7ch1	77	96	CoV2	CoV2	NNP
cord-024076-q9fw7ch1	77	97	:	:	:
cord-024076-q9fw7ch1	78	1	should	should	MD
cord-024076-q9fw7ch1	78	2	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	78	3	of	of	IN
cord-024076-q9fw7ch1	78	4	the	the	DT
cord-024076-q9fw7ch1	78	5	renin	renin	NN
cord-024076-q9fw7ch1	78	6	-	-	HYPH
cord-024076-q9fw7ch1	78	7	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	78	8	system	system	NN
cord-024076-q9fw7ch1	78	9	be	be	VB
cord-024076-q9fw7ch1	78	10	withdrawn	withdraw	VBN
cord-024076-q9fw7ch1	78	11	in	in	IN
cord-024076-q9fw7ch1	78	12	patients	patient	NNS
cord-024076-q9fw7ch1	78	13	with	with	IN
cord-024076-q9fw7ch1	78	14	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	78	15	?	?	.
cord-024076-q9fw7ch1	79	1	Cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	79	2	considerations	consideration	NNS
cord-024076-q9fw7ch1	79	3	for	for	IN
cord-024076-q9fw7ch1	79	4	patients	patient	NNS
cord-024076-q9fw7ch1	79	5	,	,	,
cord-024076-q9fw7ch1	79	6	health	health	NN
cord-024076-q9fw7ch1	79	7	care	care	NN
cord-024076-q9fw7ch1	79	8	workers	worker	NNS
cord-024076-q9fw7ch1	79	9	,	,	,
cord-024076-q9fw7ch1	79	10	and	and	CC
cord-024076-q9fw7ch1	79	11	health	health	NN
cord-024076-q9fw7ch1	79	12	systems	system	NNS
cord-024076-q9fw7ch1	79	13	during	during	IN
cord-024076-q9fw7ch1	79	14	the	the	DT
cord-024076-q9fw7ch1	79	15	coronavirus	coronavirus	NN
cord-024076-q9fw7ch1	79	16	disease	disease	NN
cord-024076-q9fw7ch1	79	17	2019	2019	CD
cord-024076-q9fw7ch1	79	18	(	(	-LRB-
cord-024076-q9fw7ch1	79	19	COVID-19	covid-19	VB
cord-024076-q9fw7ch1	79	20	)	)	-RRB-
cord-024076-q9fw7ch1	79	21	pandemic	pandemic	NN
cord-024076-q9fw7ch1	79	22	Inflammation	inflammation	NN
cord-024076-q9fw7ch1	79	23	in	in	IN
cord-024076-q9fw7ch1	79	24	atherosclerosis	atherosclerosis	NN
cord-024076-q9fw7ch1	79	25	:	:	:
cord-024076-q9fw7ch1	79	26	from	from	IN
cord-024076-q9fw7ch1	79	27	pathophysiology	pathophysiology	NN
cord-024076-q9fw7ch1	79	28	to	to	TO
cord-024076-q9fw7ch1	79	29	practice	practice	VB
cord-024076-q9fw7ch1	79	30	Withdrawal	withdrawal	NN
cord-024076-q9fw7ch1	79	31	of	of	IN
cord-024076-q9fw7ch1	79	32	pharmacological	pharmacological	JJ
cord-024076-q9fw7ch1	79	33	treatment	treatment	NN
cord-024076-q9fw7ch1	79	34	for	for	IN
cord-024076-q9fw7ch1	79	35	heart	heart	NN
cord-024076-q9fw7ch1	79	36	failure	failure	NN
cord-024076-q9fw7ch1	79	37	in	in	IN
cord-024076-q9fw7ch1	79	38	patients	patient	NNS
cord-024076-q9fw7ch1	79	39	with	with	IN
cord-024076-q9fw7ch1	79	40	recovered	recovered	JJ
cord-024076-q9fw7ch1	79	41	dilated	dilated	JJ
cord-024076-q9fw7ch1	79	42	cardiomyopathy	cardiomyopathy	NN
cord-024076-q9fw7ch1	79	43	(	(	-LRB-
cord-024076-q9fw7ch1	79	44	TRED	TRED	NNP
cord-024076-q9fw7ch1	79	45	-	-	HYPH
cord-024076-q9fw7ch1	79	46	HF	HF	NNP
cord-024076-q9fw7ch1	79	47	)	)	-RRB-
cord-024076-q9fw7ch1	79	48	:	:	:
cord-024076-q9fw7ch1	79	49	an	an	DT
cord-024076-q9fw7ch1	79	50	open	open	JJ
cord-024076-q9fw7ch1	79	51	-	-	HYPH
cord-024076-q9fw7ch1	79	52	label	label	NN
cord-024076-q9fw7ch1	79	53	,	,	,
cord-024076-q9fw7ch1	79	54	pilot	pilot	NN
cord-024076-q9fw7ch1	79	55	,	,	,
cord-024076-q9fw7ch1	79	56	randomised	randomised	JJ
cord-024076-q9fw7ch1	79	57	trial	trial	NN
cord-024076-q9fw7ch1	79	58	ESC	ESC	NNP
cord-024076-q9fw7ch1	79	59	/	/	SYM
cord-024076-q9fw7ch1	79	60	ESH	ESH	NNP
cord-024076-q9fw7ch1	79	61	Guidelines	Guidelines	NNPS
cord-024076-q9fw7ch1	79	62	for	for	IN
cord-024076-q9fw7ch1	79	63	the	the	DT
cord-024076-q9fw7ch1	79	64	management	management	NN
cord-024076-q9fw7ch1	79	65	of	of	IN
cord-024076-q9fw7ch1	79	66	arterial	arterial	JJ
cord-024076-q9fw7ch1	79	67	hypertension	hypertension	NN
cord-024076-q9fw7ch1	79	68	:	:	:
cord-024076-q9fw7ch1	79	69	The	the	DT
cord-024076-q9fw7ch1	79	70	Task	Task	NNP
cord-024076-q9fw7ch1	79	71	Force	Force	NNP
cord-024076-q9fw7ch1	79	72	for	for	IN
cord-024076-q9fw7ch1	79	73	the	the	DT
cord-024076-q9fw7ch1	79	74	management	management	NN
cord-024076-q9fw7ch1	79	75	of	of	IN
cord-024076-q9fw7ch1	79	76	arterial	arterial	JJ
cord-024076-q9fw7ch1	79	77	hypertension	hypertension	NN
cord-024076-q9fw7ch1	79	78	of	of	IN
cord-024076-q9fw7ch1	79	79	the	the	DT
cord-024076-q9fw7ch1	79	80	European	European	NNP
cord-024076-q9fw7ch1	79	81	Society	Society	NNP
cord-024076-q9fw7ch1	79	82	of	of	IN
cord-024076-q9fw7ch1	79	83	Cardiology	Cardiology	NNP
cord-024076-q9fw7ch1	79	84	(	(	-LRB-
cord-024076-q9fw7ch1	79	85	ESC	ESC	NNP
cord-024076-q9fw7ch1	79	86	)	)	-RRB-
cord-024076-q9fw7ch1	79	87	and	and	CC
cord-024076-q9fw7ch1	79	88	the	the	DT
cord-024076-q9fw7ch1	79	89	European	European	NNP
cord-024076-q9fw7ch1	79	90	Society	Society	NNP
cord-024076-q9fw7ch1	79	91	of	of	IN
cord-024076-q9fw7ch1	79	92	Hypertension	Hypertension	NNP
cord-024076-q9fw7ch1	80	1	(	(	-LRB-
cord-024076-q9fw7ch1	80	2	ESH	ESH	NNP
cord-024076-q9fw7ch1	80	3	)	)	-RRB-
cord-024076-q9fw7ch1	80	4	ESC	ESC	NNP
cord-024076-q9fw7ch1	80	5	Guidelines	Guidelines	NNPS
cord-024076-q9fw7ch1	80	6	for	for	IN
cord-024076-q9fw7ch1	80	7	the	the	DT
cord-024076-q9fw7ch1	80	8	management	management	NN
cord-024076-q9fw7ch1	80	9	of	of	IN
cord-024076-q9fw7ch1	80	10	acute	acute	JJ
cord-024076-q9fw7ch1	80	11	myocardial	myocardial	JJ
cord-024076-q9fw7ch1	80	12	infarction	infarction	NN
cord-024076-q9fw7ch1	80	13	in	in	IN
cord-024076-q9fw7ch1	80	14	patients	patient	NNS
cord-024076-q9fw7ch1	80	15	presenting	present	VBG
cord-024076-q9fw7ch1	80	16	with	with	IN
cord-024076-q9fw7ch1	80	17	ST	ST	NNP
cord-024076-q9fw7ch1	80	18	-	-	HYPH
cord-024076-q9fw7ch1	80	19	segment	segment	NN
cord-024076-q9fw7ch1	80	20	elevation	elevation	NN
cord-024076-q9fw7ch1	80	21	:	:	:
cord-024076-q9fw7ch1	80	22	the	the	DT
cord-024076-q9fw7ch1	80	23	Task	Task	NNP
cord-024076-q9fw7ch1	80	24	Force	Force	NNP
cord-024076-q9fw7ch1	80	25	for	for	IN
cord-024076-q9fw7ch1	80	26	the	the	DT
cord-024076-q9fw7ch1	80	27	management	management	NN
cord-024076-q9fw7ch1	80	28	of	of	IN
cord-024076-q9fw7ch1	80	29	acute	acute	JJ
cord-024076-q9fw7ch1	80	30	myocardial	myocardial	JJ
cord-024076-q9fw7ch1	80	31	infarction	infarction	NN
cord-024076-q9fw7ch1	80	32	in	in	IN
cord-024076-q9fw7ch1	80	33	patients	patient	NNS
cord-024076-q9fw7ch1	80	34	presenting	present	VBG
cord-024076-q9fw7ch1	80	35	with	with	IN
cord-024076-q9fw7ch1	80	36	ST	ST	NNP
cord-024076-q9fw7ch1	80	37	-	-	HYPH
cord-024076-q9fw7ch1	80	38	segment	segment	NN
cord-024076-q9fw7ch1	80	39	elevation	elevation	NN
cord-024076-q9fw7ch1	80	40	of	of	IN
cord-024076-q9fw7ch1	80	41	the	the	DT
cord-024076-q9fw7ch1	80	42	European	European	NNP
cord-024076-q9fw7ch1	80	43	Society	Society	NNP
cord-024076-q9fw7ch1	80	44	of	of	IN
cord-024076-q9fw7ch1	80	45	Cardiology	Cardiology	NNP
cord-024076-q9fw7ch1	80	46	Outcomes	Outcomes	NNPS
cord-024076-q9fw7ch1	80	47	in	in	IN
cord-024076-q9fw7ch1	80	48	hypertensive	hypertensive	JJ
cord-024076-q9fw7ch1	80	49	patients	patient	NNS
cord-024076-q9fw7ch1	80	50	at	at	IN
cord-024076-q9fw7ch1	80	51	high	high	JJ
cord-024076-q9fw7ch1	80	52	cardiovascular	cardiovascular	JJ
cord-024076-q9fw7ch1	80	53	risk	risk	NN
cord-024076-q9fw7ch1	80	54	treated	treat	VBN
cord-024076-q9fw7ch1	80	55	with	with	IN
cord-024076-q9fw7ch1	80	56	regimens	regimen	NNS
cord-024076-q9fw7ch1	80	57	based	base	VBN
cord-024076-q9fw7ch1	80	58	on	on	IN
cord-024076-q9fw7ch1	80	59	valsartan	valsartan	NNP
cord-024076-q9fw7ch1	80	60	or	or	CC
cord-024076-q9fw7ch1	80	61	amlodipine	amlodipine	NN
cord-024076-q9fw7ch1	80	62	:	:	:
cord-024076-q9fw7ch1	80	63	the	the	DT
cord-024076-q9fw7ch1	80	64	VALUE	value	NN
cord-024076-q9fw7ch1	80	65	randomised	randomised	JJ
cord-024076-q9fw7ch1	80	66	trial	trial	NN
cord-024076-q9fw7ch1	80	67	Position	Position	NNP
cord-024076-q9fw7ch1	80	68	statement	statement	NN
cord-024076-q9fw7ch1	80	69	of	of	IN
cord-024076-q9fw7ch1	80	70	the	the	DT
cord-024076-q9fw7ch1	80	71	ESC	ESC	NNP
cord-024076-q9fw7ch1	80	72	Council	Council	NNP
cord-024076-q9fw7ch1	80	73	on	on	IN
cord-024076-q9fw7ch1	80	74	Hypertension	Hypertension	NNP
cord-024076-q9fw7ch1	80	75	on	on	IN
cord-024076-q9fw7ch1	80	76	ACE	ace	NN
cord-024076-q9fw7ch1	80	77	-	-	HYPH
cord-024076-q9fw7ch1	80	78	inhibitors	inhibitor	NNS
cord-024076-q9fw7ch1	80	79	and	and	CC
cord-024076-q9fw7ch1	80	80	angiotensin	angiotensin	NN
cord-024076-q9fw7ch1	80	81	receptor	receptor	NN
cord-024076-q9fw7ch1	80	82	blockers	blocker	NNS
cord-024076-q9fw7ch1	81	1	HFSA	HFSA	NNP
cord-024076-q9fw7ch1	81	2	/	/	SYM
cord-024076-q9fw7ch1	81	3	ACC	ACC	NNP
cord-024076-q9fw7ch1	81	4	/	/	SYM
cord-024076-q9fw7ch1	81	5	AHA	AHA	NNP
cord-024076-q9fw7ch1	81	6	statement	statement	NN
cord-024076-q9fw7ch1	81	7	addresses	address	VBZ
cord-024076-q9fw7ch1	81	8	concerns	concern	NNS
cord-024076-q9fw7ch1	81	9	re	re	IN
cord-024076-q9fw7ch1	81	10	:	:	:
cord-024076-q9fw7ch1	81	11	using	use	VBG
cord-024076-q9fw7ch1	81	12	RAAS	RAAS	NNP
cord-024076-q9fw7ch1	81	13	antagonists	antagonist	NNS
cord-024076-q9fw7ch1	81	14	in	in	IN
cord-024076-q9fw7ch1	81	15	COVID-19	COVID-19	NNP
cord-024076-q9fw7ch1	81	16	Angiotensin	Angiotensin	NNP
cord-024076-q9fw7ch1	81	17	-	-	HYPH
cord-024076-q9fw7ch1	81	18	converting	convert	VBG
cord-024076-q9fw7ch1	81	19	enzyme	enzyme	NN
cord-024076-q9fw7ch1	81	20	2	2	CD
cord-024076-q9fw7ch1	81	21	(	(	-LRB-
cord-024076-q9fw7ch1	81	22	ACE2	ACE2	NNP
cord-024076-q9fw7ch1	81	23	)	)	-RRB-
cord-024076-q9fw7ch1	81	24	as	as	IN
cord-024076-q9fw7ch1	81	25	a	a	DT
cord-024076-q9fw7ch1	81	26	SARS	SARS	NNP
cord-024076-q9fw7ch1	81	27	-	-	HYPH
cord-024076-q9fw7ch1	81	28	CoV-2	CoV-2	NNP
cord-024076-q9fw7ch1	81	29	receptor	receptor	NN
cord-024076-q9fw7ch1	81	30	:	:	:
cord-024076-q9fw7ch1	81	31	molecular	molecular	JJ
cord-024076-q9fw7ch1	81	32	mechanisms	mechanism	NNS
cord-024076-q9fw7ch1	81	33	and	and	CC
cord-024076-q9fw7ch1	81	34	potential	potential	JJ
cord-024076-q9fw7ch1	81	35	therapeutic	therapeutic	JJ
cord-024076-q9fw7ch1	81	36	target	target	NN